{"gene":"GZMB","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1987,"finding":"GZMB (clone 1-3E) encodes a 247-residue serine protease induced in mitogen-stimulated human T lymphocytes; its mRNA is expressed specifically in T lymphocyte clones and is most closely related (68% homology) to murine cytotoxic T lymphocyte protease CCPI.","method":"cDNA cloning and sequencing, Northern blot expression analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — original molecular cloning with sequence identity and expression characterization","pmids":["2953813"],"is_preprint":false},{"year":1988,"finding":"The GZMB gene (CCPII) shares a gene organization with other serine protease genes in which each active-site residue is on a separate exon; two introns occur at unique positions — one within the activation dipeptide and one interrupting the invariant core region near the active-site Asp — defining GZMB as a new subfamily of serine protease genes.","method":"Genomic cloning, sequencing, and gene structure analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct genomic sequencing establishing gene architecture and active-site exon organization","pmids":["3264185"],"is_preprint":false},{"year":1990,"finding":"Transcriptional activation of CSP-B/GZMB in T lymphocytes requires synergistic action of TPA and cAMP (bt2cAMP); neither agent alone activates transcription. Upon activation, a DNase I-hypersensitive site forms upstream from the gene, and the region −615 to −63 functions as an orientation-specific upstream promoter element.","method":"Transient transfection of promoter-reporter constructs, DNase I hypersensitivity assay, Northern blot","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — functional promoter mapping with mutagenesis and chromatin analysis, multiple methods","pmids":["2233710"],"is_preprint":false},{"year":1991,"finding":"The 5′-flanking region of the human GZMB (CSP-B/CGL-1) gene is sufficient to drive expression specifically in activated T lymphocytes in vivo; expression is induced by ConA or IL-2 (but not in resting cells), responding to signals from both the TCR and the IL-2 receptor.","method":"Transgenic mouse reporter assay (human growth hormone driven by CSP-B promoter)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo promoter function established in multiple transgenic founder lines","pmids":["1761544"],"is_preprint":false},{"year":1993,"finding":"A consensus AP-1 element and a consensus CRE located 5′ to the GZMB transcriptional start site both are required and synergize for transcriptional activation; the AP-1 site is dominant (replacement with a second AP-1 retains activity, but replacement with a CRE abolishes it); helical spacing between the two elements is critical, suggesting cooperative DNA-bound factor interactions.","method":"Transient transfection of promoter constructs with point mutations and deletions in PEER T cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — systematic site-directed mutagenesis of promoter elements with functional readout","pmids":["8219227"],"is_preprint":false},{"year":1996,"finding":"Proteinase inhibitor 9 (PI-9/SERPINB9) forms an SDS-resistant covalent complex with granzyme B with a second-order rate constant of 1.7×10⁶ M⁻¹s⁻¹, completely abrogates granzyme B– and perforin-mediated cytotoxicity in vitro, and is a cytosolic (not secreted) protein present in a separate subcellular compartment from granzyme B in NK cells — functioning as an endogenous inhibitor that protects cytotoxic lymphocytes from misdirected granzyme B.","method":"Recombinant protein production, serpin-protease complex assay, kinetic analysis, cytotoxicity assay, subcellular fractionation, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with kinetics, multiple orthogonal methods, functional validation","pmids":["8910377"],"is_preprint":false},{"year":1996,"finding":"Granzyme B can process pro-Mch2alpha (caspase-6) and pro-Mch6 (caspase-14/caspase-9 homolog), but cleavage of pro-Mch2alpha by granzyme B alone is insufficient; granzyme B must first activate CPP32 (caspase-3), which then processes pro-Mch2alpha to generate active lamin-cleaving enzyme — establishing a protease cascade: granzyme B → caspase-3 → caspase-6/lamin cleavage.","method":"In vitro cleavage assays with recombinant proteins, site-directed mutagenesis, cell-free extract reconstitution","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis demonstrating cascade order","pmids":["8900201"],"is_preprint":false},{"year":1998,"finding":"Granzyme B directly and efficiently cleaves downstream caspase substrates DNA-PKcs and NuMA in vitro and in vivo, generating cleavage fragments distinct from those produced by caspases, demonstrating a caspase-independent direct proteolytic execution pathway.","method":"In vitro cleavage assays, cell-free apoptosis system, immunoblot of cleavage products in CTL-treated cells","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — in vitro and in vivo substrate cleavage with unique fragment identification","pmids":["9586635"],"is_preprint":false},{"year":2000,"finding":"Granzyme B initiates apoptosis through the mitochondrial pathway by directly cleaving Bid; this Bid cleavage occurs upstream of and independently of mitochondrial Bcl-2, is not delayed by caspase inhibition, and is required (mutation of GrB cleavage site in Bid abolishes apoptosis restoration) — placing direct Bid cleavage as the essential upstream step in GrB-mediated mitochondrial pathway activation.","method":"Bcl-2-overexpressing cell lines, Bid mutants (cleavage site and BH3 domain mutations), granzyme B treatment with caspase inhibitors, flow cytometry of mitochondrial membrane potential","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with multiple Bid mutants, epistasis with Bcl-2, replicated in multiple cell models","pmids":["11085743"],"is_preprint":false},{"year":2000,"finding":"The cation-independent mannose 6-phosphate receptor (CI-MPR/IGF2R) is identified as a cell-surface receptor for granzyme B; blocking this interaction prevents GrB binding, uptake, and apoptosis induction; CI-MPR expression is required for CTL-mediated apoptosis in vitro and for allogeneic cell rejection in vivo.","method":"Receptor blocking with antibodies/ligands, CI-MPR-deficient cells, in vitro cytotoxicity assay, in vivo allograft rejection model","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function in vitro and in vivo, multiple blocking approaches, functional readouts","pmids":["11081635"],"is_preprint":false},{"year":2001,"finding":"Rab27a, which colocalizes with granzyme B-positive secretory granules, is required for a late step in granule exocytosis; Rab27a-deficient (ashen) CTLs have normal perforin and granzyme A/B levels and normal granule polarization, but show >90% reduction in granule-mediated cytotoxicity and drastically defective rapid anti-CD3-induced granule secretion.","method":"Rab27a-deficient ashen mouse CTLs, granule polarization assay, cytotoxicity assay, granzyme secretion measurement, immunofluorescence colocalization","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO model with multiple functional assays, colocalization demonstrating Rab27a-GzmB granule association","pmids":["11266473"],"is_preprint":false},{"year":2002,"finding":"Granzyme B and perforin co-exist as multimeric complexes with the proteoglycan serglycin in cytotoxic granules, and cytotoxic cells secrete exclusively macromolecular GrB-serglycin complexes; perforin mediates cytosolic delivery of these macromolecular GrB-serglycin complexes without producing detectable plasma membrane pores.","method":"Granule biochemistry, size-exclusion chromatography, ELISA, electron microscopy, membrane permeabilization assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution of GrB-serglycin complex with functional delivery assay","pmids":["11911826"],"is_preprint":false},{"year":2003,"finding":"Granzyme B functions as a caspase-like serine protease released by cytotoxic lymphocytes; PI-9 (SERPINB9) regulates its function in lymphocytes; granzyme B can enter and traffic within target cells and triggers cell death through Bid cleavage and caspase activation.","method":"Review synthesizing biochemical and cell biological evidence from multiple primary studies","journal":"Current opinion in immunology","confidence":"High","confidence_rationale":"Tier 1–2 — review of replicated mechanistic findings across multiple labs","pmids":["14499262"],"is_preprint":false},{"year":2004,"finding":"Granzyme B is differentially expressed in human lymphocyte subsets: most CD56+CD8− NK cells and ~50% of CD8+ T cells co-express granzymes A and B; activation with ConA/IL-2 or anti-CD3/CD46 strongly induces granzyme B (but not A) in both CD8+ and CD4+ T cells; granzyme B-expressing CD4+ Tr1 cells kill target cells in a perforin-dependent, MHC/TCR-independent manner.","method":"Flow cytometry (intracellular staining), activation assays, perforin-dependent killing assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — comprehensive characterization across lymphocyte subsets with functional killing validation","pmids":["15238416"],"is_preprint":false},{"year":2005,"finding":"Human granzyme B cleaves extracellular matrix proteins vitronectin (after an RGD motif), fibronectin, and laminin, causing cell detachment and anoikis of endothelial cells, and inhibiting tumor cell spreading, migration, and invasion — revealing a perforin-independent ECM remodeling activity of secreted granzyme B.","method":"In vitro cleavage assays with purified ECM proteins, cell detachment and anoikis assays, migration/invasion assays, cleavage site mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro substrate cleavage combined with multiple cell biological functional assays","pmids":["15843372"],"is_preprint":false},{"year":2009,"finding":"Granzyme B-induced apoptosis of ectromelia-infected target cells is totally dependent on caspase-3/-7 (not Bid/Bak/Bax pathway); ectromelia virus can partially block GzmB-induced apoptosis when caspase-3/-7 is the only available pathway, but inhibition of viral replication in vitro was significantly reduced only in caspase-3/-7-deficient cells — establishing caspase-3/-7 as the critical pathway for GzmB-mediated viral control.","method":"Ex vivo immune Tc cells from GzmA-KO and GzmAxB-DKO mice, caspase-3/-7-deficient and Bid/Bak/Bax-deficient target cells, viral titer measurement, apoptosis assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — genetic KO of multiple pathway components with physiological viral infection model","pmids":["19838298"],"is_preprint":false},{"year":2011,"finding":"Human miR-27a* is a negative regulator of NK cell cytotoxicity by directly binding the 3′UTR of both Prf1 and GzmB mRNAs and down-regulating their expression in both resting and activated NK cells; knockdown of miR-27a* in NK cells dramatically increases cytotoxicity in vitro and decreases tumor growth in a xenograft model.","method":"3′UTR luciferase reporter assay, miRNA overexpression/knockdown, NK cell cytotoxicity assay, tumor xenograft model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — direct 3′UTR binding validated by reporter assay, functional in vitro and in vivo validation","pmids":["21960590"],"is_preprint":false},{"year":2013,"finding":"Hypoxia-induced autophagy in breast cancer cells causes selective degradation of NK-derived granzyme B in autophagosomes, blocking NK-mediated target cell apoptosis; inhibition of autophagy by targeting BECN1 restores granzyme B levels in hypoxic cells and induces tumor regression in vivo by facilitating NK killing.","method":"Autophagy inhibition (BECN1 knockdown), GrB immunofluorescence/colocalization with autophagosomes, NK cytotoxicity assay, in vivo tumor regression model","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway (autophagosomal degradation) with in vitro and in vivo validation","pmids":["24101526"],"is_preprint":false},{"year":2013,"finding":"Hypoxia-induced autophagy impairs breast cancer cell susceptibility to NK-mediated lysis by selectively degrading GZMB in autophagosomes of hypoxic cells, thereby blocking NK-mediated apoptosis; targeting autophagy reverses this and promotes tumor regression in vivo.","method":"Autophagy activation/inhibition, GZMB immunofluorescence, autophagosome-lysosome colocalization, NK cytotoxicity assay, in vivo xenograft","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — replication of autophagosomal GZMB degradation mechanism from companion paper with additional functional data","pmids":["24248158"],"is_preprint":false},{"year":2013,"finding":"Perforin forms transient pores on the target cell plasma membrane within 30 seconds of cytotoxic lymphocyte recognition, allowing rapid diffusion of extracellular granzymes into the synaptic cleft and entry into target cells; pore repair begins within 20 seconds and is complete within 80 seconds, yet this brief window is sufficient to deliver lethal granzyme B amounts triggering caspase-dependent apoptosis within 2 minutes.","method":"Time-lapse microscopy of human primary CTLs at immunological synapses, calcium flux assays, pore kinetics, caspase activity monitoring","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — direct real-time imaging of physiological synapse with quantitative kinetic measurements","pmids":["23377437"],"is_preprint":false},{"year":2015,"finding":"miR-378 (but not miR-27a* or miR-30e) suppresses GzmB expression in NK cells during dengue virus infection; overexpression of miR-378 in DENV-infected mice inhibited GzmB expression and promoted DENV replication, establishing miR-378 as a critical regulator of GzmB-mediated NK cell control of viral infection.","method":"miRNA agomir overexpression in vivo, GzmB expression measurement (flow cytometry), viral titer measurement in infected mice","journal":"Cellular & molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo functional validation but no direct 3′UTR binding assay reported for miR-378/GzmB","pmids":["26166761"],"is_preprint":false},{"year":2017,"finding":"QPY/RAH polymorphism (rs8192917; Q48R) in the GZMB gene influences NK cell cytotoxicity; R48-GzmB accumulates to similar levels as Q48-GzmB in activated NK cells but NK cell cytotoxicity is significantly influenced by this non-synonymous SNP, suggesting the R48 variant alters functional activity rather than protein stability.","method":"Genotyping of NK cell donors, NK cytotoxicity assay (51Cr release), GzmB protein quantification by flow cytometry/ELISA, degranulation assay","journal":"Immunogenetics","confidence":"Medium","confidence_rationale":"Tier 3 — functional NK cell assays correlating genotype with cytotoxic activity, single study","pmids":["28653095"],"is_preprint":false},{"year":2020,"finding":"Granzyme B directly cleaves GSDME (Gasdermin E) at the same site as caspase-3, converting apoptosis to pyroptosis in target cells; GSDME-mediated pyroptosis triggered by killer cell granzyme B enhances anti-tumor immunity through increased phagocytosis by macrophages and augmented NK and CD8+ T cell tumor infiltration; uncleavable or pore-defective GSDME abolishes tumor suppression.","method":"In vitro GrB cleavage assay with recombinant GSDME, GSDME knockout/knockin mice, perforin-deficient mice, lymphocyte depletion, tumor growth assays, macrophage phagocytosis assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of direct cleavage, multiple genetic KO models, replicated with multiple orthogonal approaches","pmids":["32188940"],"is_preprint":false},{"year":2020,"finding":"CAR T cell-released granzyme B cleaves GSDME in target (B leukemic) cells, activating caspase 3-dependent pyroptosis; pyroptosis-released factors then activate caspase 1 for GSDMD cleavage in macrophages, triggering cytokine release syndrome (CRS); GSDME knockout or macrophage depletion eliminates CRS in mouse models.","method":"GSDME knockout target cells, macrophage depletion, caspase 1 inhibition, CAR T cell co-culture, CRS mouse model, GrB quantification","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic KO models establishing GrB→GSDME→macrophage CRS cascade","pmids":["31953257"],"is_preprint":false},{"year":2021,"finding":"The transcription factor SP1 represses GZMB expression in lung cancer cells; inhibiting SP1 (via AuNPs-siRNA-SP1) upregulates GZMB, promotes G2/M arrest, increases DNA double-strand breaks, and enhances radiosensitivity both in vitro and in vivo.","method":"SP1 siRNA knockdown, Western blot, RT-qPCR, colony formation assay, flow cytometry cell cycle and apoptosis, immunofluorescence (γH2AX), xenograft tumor model","journal":"Translational oncology","confidence":"Medium","confidence_rationale":"Tier 2 — SP1-GZMB regulatory axis established by knockdown with multiple functional readouts, single lab","pmids":["34517158"],"is_preprint":false},{"year":2022,"finding":"Tcf-1B expression in CD8+ T cells prohibits acquisition of a GzmB-high state during effector differentiation, protecting TCR-engineered T cells from activation-induced cell death (fratricidal GzmB-mediated apoptosis) and promoting stem cell-like persistence.","method":"Constitutive Tcf-1B expression in CD8+ T cells, flow cytometry of GzmB expression, apoptosis assays, in vitro anti-tumor activity, in vivo xenograft model","journal":"Cancer immunology, immunotherapy","confidence":"Medium","confidence_rationale":"Tier 2 — direct manipulation of Tcf-1B with GzmB phenotypic readout, in vitro and in vivo, single lab","pmids":["35460379"],"is_preprint":false},{"year":2023,"finding":"GZMB activates the caspase-3–GSDME (Gasdermin E) pyroptosis pathway in rheumatoid arthritis synovial cells; GZMB silencing reduces caspase-3 and GSDME activation, decreases pyroptosis markers (LDH, IL-1β, IL-18), and reduces cell proliferation in HFLS-RA and MH7A cells.","method":"GZMB siRNA knockdown, CCK8 and EDU proliferation assays, LDH assay, ELISA (IL-1β, IL-18), Western blot of GZMB/caspase-3/GSDME","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with multiple pathway readouts, single lab","pmids":["37531918"],"is_preprint":false},{"year":2024,"finding":"GZMB inhibition (by SerpinA3N) in diabetic mice reduces endoplasmic reticulum stress (PERK/eIF2α pathway) and pyroptosis (NLRP3/caspase-1/GSDMD-N/IL-1β/IL-18) in hippocampal oligodendrocytes, reduces demyelination (restores MBP and CNPase expression), and ameliorates cognitive dysfunction — establishing GZMB as a promoter of oligodendrocyte ER stress and pyroptosis leading to demyelination.","method":"Streptozotocin diabetic mouse model, SerpinA3N (GZMB inhibitor) treatment, Morris water maze, immunofluorescence, Luxol Fast Blue staining, electron microscopy, Western blot","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibition of GZMB with multiple pathway readouts in vivo, single lab","pmids":["39326683"],"is_preprint":false},{"year":2024,"finding":"CRISPR-Cas9 knockout of GZMB (alongside PRF1, LYST, or IFNγ) in primary human CD8+ T cells significantly diminishes their in vitro immune suppressive ability, establishing that GZMB is required for CD8+ T cell-mediated immune suppression.","method":"CRISPR-Cas9 RNP knockout in primary human CD8+ T cells, RT-qPCR and flow cytometry confirmation of KO, in vitro T cell suppression assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — clean CRISPR KO in primary human cells with specific functional suppression readout","pmids":["38607279"],"is_preprint":false},{"year":2026,"finding":"NK cell-derived GZMB suppresses glioblastoma radioresistance by directly cleaving SDC1 (syndecan-1) at valine-225 and aspartate-228 sites, blocking autophagosome-lysosome fusion; SDC1 cleavage disrupts TGM2 localization on the lysosome surface (a key LC3 recognizer), impairing autophagosome maturation and thereby radiosensitizing GBM cells.","method":"Co-culture NK/GBM experiments, GZMB activity inhibition, exogenous recombinant GZMB, in vitro cleavage assay identifying SDC1 cleavage sites, uncleavable SDC1 mutant rescue experiment, TGM2 lysosome localization assay, xenograft model, clinical data correlation","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1 — direct substrate cleavage site identified, uncleavable mutant reversal, multiple functional assays, in vivo validation","pmids":["41378763"],"is_preprint":false},{"year":2025,"finding":"In CD4+ cytotoxic T cells (TCTX) in untreated tumors, Gzmb mRNA is abundant but Granzyme B protein is limited (poised state); anti-CTLA-4 or anti-LAG-3+anti-PD-1 treatment removes this post-transcriptional block by repressing the RNA-binding protein Zfp36l1; constitutive Zfp36l1 expression abrogates anti-CTLA-4 effects on GzmB protein, while deletion of Zfp36l1 and its paralog Zfp36 triggers GzmB protein production and promotes tumor control.","method":"Zfp36l1 constitutive expression and genetic deletion, anti-CTLA-4/anti-LAG-3+PD-1 treatment, GzmB protein vs. mRNA quantification, tumor growth assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — genetic gain/loss-of-function with mechanistic pathway placement, preprint pending peer review","pmids":[],"is_preprint":true},{"year":2025,"finding":"IFNγ is stored within GzmB+ cytotoxic granules in activated mouse and human CD8+ T cells ('lytic IFNγ') and is co-secreted with GzmB at the immunological synapse; Munc13-4-deficient T cells show impaired both cytotoxic granule and early IFNγ release at the synapse, linking GzmB granule exocytosis machinery to IFNγ secretion.","method":"Super-resolution imaging, Munc13-4 KO T cells, time-lapse microscopy of immunological synapses, granule-IFNγ colocalization, SMAP isolation","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — direct co-localization with genetic KO confirmation, preprint","pmids":[],"is_preprint":true},{"year":2025,"finding":"Granzyme-targeting quenched activity-based probe Cy5-IEPCya(Ph)P-QSY21 reacts rapidly with GzmB at substoichiometric concentrations and enables selective labeling of the active enzyme in complex proteomes; in vivo fluorescence signals correlate with GzmB expression/activity and CD8+ cell density in tumor tissues.","method":"Activity-based probe synthesis, in vitro selectivity assays, in vivo optical imaging in immunotherapy-treated mice, ex vivo correlation with GzmB expression","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 — direct active-site probe with functional validation in vivo, preprint","pmids":[],"is_preprint":true},{"year":2025,"finding":"Supramolecular attack particles (SMAPs) enriched from NK-92 cell cultures contain GZMB and PRF1 as core cytotoxic components; Ca2+-stabilized SMAPs trigger caspase-3-dependent apoptosis in tumor cell lines in a dose-dependent manner, and restrain tumor growth in NSG mice bearing B16F10 melanoma and PANC-1 pancreatic cancer.","method":"Serial size-exclusion chromatography SMAP isolation, proteomics, nano flow cytometry, TEM, TIRFM, caspase-3 apoptosis assay, NSG mouse xenograft models","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical characterization of GZMB-containing particles with functional caspase-dependent cytotoxicity validation, preprint","pmids":[],"is_preprint":true}],"current_model":"GZMB encodes a caspase-like serine protease stored with perforin and serglycin in cytotoxic granules of CTLs and NK cells; upon immunological synapse formation, perforin transiently permeabilizes the target cell plasma membrane allowing GzmB entry (facilitated by CI-MPR/IGF2R receptor-mediated uptake), whereupon GzmB initiates apoptosis primarily by directly cleaving Bid to activate the mitochondrial pathway and by activating caspase-3 (which cleaves downstream substrates including GSDME to trigger pyroptosis), can also directly cleave caspase substrates (DNA-PKcs, NuMA) in a caspase-independent manner, remodels ECM by cleaving vitronectin/fibronectin/laminin, and blocks autophagosome maturation by cleaving SDC1; its expression is transcriptionally controlled by AP-1/CRE promoter elements and post-transcriptionally regulated by miR-27a* and ZFP36L1, while cytosolic SERPINB9/PI-9 protects cytotoxic lymphocytes from self-inflicted GzmB damage, and Rab27a is required for GzmB-containing granule exocytosis."},"narrative":{"teleology":[{"year":1987,"claim":"Molecular cloning established GZMB as a novel serine protease gene specifically induced in activated human T lymphocytes, resolving the molecular identity of granule-associated cytotoxic protease activity.","evidence":"cDNA cloning, sequencing, and Northern blot in mitogen-stimulated T cell clones","pmids":["2953813"],"confidence":"High","gaps":["enzymatic specificity and substrates unknown","no functional cytotoxicity assay performed"]},{"year":1988,"claim":"Gene structure analysis revealed GZMB encodes each catalytic triad residue on a separate exon with two unique intron positions, placing it in a distinct serine protease subfamily separate from classical trypsin-like enzymes.","evidence":"genomic cloning and intron–exon mapping","pmids":["3264185"],"confidence":"High","gaps":["substrate specificity not yet determined","relationship between gene structure and Asp-ase activity unexplored"]},{"year":1993,"claim":"Mapping the transcriptional control of GZMB showed that synergistic action of an AP-1 element and a CRE in the promoter, with critical helical spacing, drives T cell–specific expression in response to TCR and IL-2 receptor signals.","evidence":"promoter-reporter mutagenesis in T cell lines (1990–1993) and transgenic mouse reporter assays (1991)","pmids":["2233710","1761544","8219227"],"confidence":"High","gaps":["identity of transcription factor complexes binding the AP-1/CRE composite element not resolved","chromatin-level regulation not addressed"]},{"year":1996,"claim":"Two key mechanistic questions were answered simultaneously: SERPINB9/PI-9 was identified as a fast-acting cytosolic inhibitor that protects killer cells from self-inflicted GzmB damage, and GzmB was shown to initiate a caspase cascade by activating caspase-3, which then processes caspase-6 to cleave lamins.","evidence":"recombinant serpin–protease kinetics and cytotoxicity inhibition assay; in vitro cleavage cascade reconstitution with caspase mutagenesis","pmids":["8910377","8900201"],"confidence":"High","gaps":["upstream initiating event in target cells (mitochondrial vs. direct caspase activation) unresolved","physiological relevance of PI-9 in vivo not tested"]},{"year":1998,"claim":"Discovery that GzmB directly cleaves nuclear substrates DNA-PKcs and NuMA generating fragments distinct from caspase products established a parallel caspase-independent execution pathway.","evidence":"in vitro cleavage assays and immunoblots of CTL-treated target cells","pmids":["9586635"],"confidence":"High","gaps":["relative contribution of caspase-dependent vs. -independent pathways to cell death in vivo unknown","full substrate repertoire not defined"]},{"year":2000,"claim":"Two foundational discoveries resolved GzmB's upstream activation mechanism and entry route: direct Bid cleavage was established as the essential initiating step for mitochondrial apoptosis, and CI-MPR/IGF2R was identified as the cell-surface receptor mediating GzmB uptake.","evidence":"Bid cleavage-site and BH3 mutants with Bcl-2 epistasis; CI-MPR blocking antibodies, CI-MPR-deficient cells, and in vivo allograft rejection","pmids":["11085743","11081635"],"confidence":"High","gaps":["perforin's mechanism of cytosolic delivery versus CI-MPR endosomal uptake debated","structural basis of GzmB–CI-MPR interaction unknown"]},{"year":2001,"claim":"Rab27a was identified as essential for late-stage exocytosis of GzmB-containing cytotoxic granules, linking granule trafficking machinery to killer cell function.","evidence":"Rab27a-deficient (ashen) mouse CTLs with cytotoxicity and secretion assays","pmids":["11266473"],"confidence":"High","gaps":["downstream effectors of Rab27a at the granule membrane not identified","whether Rab27a acts identically in human CTLs untested"]},{"year":2002,"claim":"Biochemical isolation of GzmB–serglycin–perforin macromolecular complexes from granules showed that GzmB is secreted exclusively in these complexes and delivered to the cytosol by perforin without producing stable plasma membrane pores.","evidence":"granule biochemistry with size-exclusion chromatography, ELISA, and membrane permeabilization assays","pmids":["11911826"],"confidence":"High","gaps":["stoichiometry of serglycin complex not determined","mechanism by which perforin releases GzmB from serglycin in the cytosol unclear"]},{"year":2005,"claim":"Demonstration that GzmB cleaves ECM proteins vitronectin, fibronectin, and laminin revealed a perforin-independent extracellular function in ECM remodeling, cell detachment, and anoikis.","evidence":"in vitro cleavage of purified ECM substrates, cell detachment assays, migration/invasion assays","pmids":["15843372"],"confidence":"High","gaps":["in vivo relevance of ECM cleavage in tumor surveillance or tissue injury not established","full spectrum of extracellular substrates unknown"]},{"year":2013,"claim":"Real-time imaging resolved the kinetics of GzmB delivery: perforin forms transient pores lasting <80 seconds at the synapse, sufficient to deliver lethal GzmB amounts that trigger caspase activation within 2 minutes; separately, hypoxia-induced autophagy in target cells was shown to degrade internalized GzmB in autophagosomes, representing a tumor immune evasion mechanism.","evidence":"time-lapse microscopy of human CTL synapses with calcium and caspase reporters; BECN1 knockdown with NK cytotoxicity assays and in vivo tumor models","pmids":["23377437","24101526","24248158"],"confidence":"High","gaps":["molecular mechanism of GzmB recognition by autophagosomes unresolved","whether autophagy-mediated GzmB degradation occurs broadly across tumor types untested"]},{"year":2011,"claim":"Post-transcriptional regulation of GZMB by miR-27a* was established: miR-27a* directly binds the GzmB 3′UTR, suppresses protein expression, and reduces NK cytotoxicity in vitro and tumor control in vivo.","evidence":"3′UTR luciferase reporter, miRNA knockdown in NK cells, tumor xenograft model","pmids":["21960590"],"confidence":"High","gaps":["whether miR-27a* is regulated during physiological immune responses unknown","combinatorial miRNA regulation of GzmB not systematically addressed"]},{"year":2020,"claim":"GzmB was shown to directly cleave GSDME at the caspase-3 cleavage site, converting target cell apoptosis to pyroptosis; this GzmB→GSDME axis amplifies anti-tumor immunity by enhancing macrophage phagocytosis and lymphocyte infiltration, but also drives CAR T cell-associated cytokine release syndrome via secondary GSDMD activation in macrophages.","evidence":"in vitro GzmB cleavage of recombinant GSDME, GSDME-KO mice, perforin-KO mice, CAR T cell CRS model with macrophage depletion","pmids":["32188940","31953257"],"confidence":"High","gaps":["relative contribution of direct GSDME cleavage vs. caspase-3-mediated GSDME cleavage during physiological killing not quantified","structural basis of GzmB–GSDME recognition unknown"]},{"year":2024,"claim":"CRISPR knockout of GZMB in primary human CD8+ T cells demonstrated that GzmB is required not only for cytotoxicity but also for CD8+ T cell-mediated immune suppression, broadening its functional role beyond target cell killing.","evidence":"CRISPR-Cas9 RNP KO in primary human CD8+ T cells with in vitro suppression assay","pmids":["38607279"],"confidence":"High","gaps":["mechanism by which GzmB mediates suppression (target cell apoptosis vs. cytokine processing) unresolved","in vivo confirmation in regulatory CD8+ T cell context lacking"]},{"year":2025,"claim":"ZFP36L1 was identified as the post-transcriptional brake that keeps GzmB protein low despite abundant mRNA in tumor-infiltrating CD4+ cytotoxic T cells; checkpoint blockade relieves this brake, and Zfp36l1 deletion is sufficient to unleash GzmB protein and promote tumor control.","evidence":"Zfp36l1 constitutive expression and genetic deletion in CD4+ T cells with anti-CTLA-4 treatment and tumor growth assays (preprint)","pmids":[],"confidence":"Medium","gaps":["direct RNA-binding site of ZFP36L1 on GZMB mRNA not mapped","pending peer review","whether this mechanism operates in CD8+ T cells untested"]},{"year":2026,"claim":"SDC1 (syndecan-1) was identified as a direct GzmB substrate whose cleavage at Val-225/Asp-228 blocks autophagosome maturation by displacing TGM2 from lysosomes, linking GzmB's proteolytic activity to suppression of cytoprotective autophagy in glioblastoma.","evidence":"in vitro cleavage site mapping, uncleavable SDC1 mutant rescue, TGM2 lysosome localization, xenograft radiosensitization model","pmids":["41378763"],"confidence":"High","gaps":["whether SDC1 cleavage by GzmB occurs in non-GBM contexts unknown","structural mechanism of TGM2 displacement not resolved"]},{"year":null,"claim":"Key unresolved questions include the complete in vivo substrate repertoire of GzmB, the structural basis of substrate selectivity, the precise mechanism by which perforin releases GzmB from serglycin complexes into the target cytosol, and the relative contributions of the Bid/mitochondrial, direct caspase, and GSDME pyroptotic pathways across different physiological and pathological contexts.","evidence":"","pmids":[],"confidence":"High","gaps":["comprehensive in vivo substrate identification lacking","no crystal structure of GzmB–substrate complex available","perforin–serglycin dissociation mechanism unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[6,7,8,14,22,29]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,6,7,14]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[10,11,19,31]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[11,14]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,10,13,15,19,28]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,7,8,22,23]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[14]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[17,18,29]}],"complexes":["GzmB–serglycin–perforin granule complex"],"partners":["PRF1","SERPINB9","BID","CASP3","GSDME","IGF2R","RAB27A","SDC1"],"other_free_text":[]},"mechanistic_narrative":"Granzyme B (GZMB) is a caspase-like serine protease stored with perforin and serglycin in cytotoxic granules of CTLs and NK cells that initiates target cell death through both caspase-dependent and caspase-independent proteolytic pathways. Upon immunological synapse formation, perforin creates transient plasma membrane pores enabling rapid GzmB entry into target cells — facilitated by CI-MPR/IGF2R receptor-mediated uptake — where GzmB directly cleaves Bid to activate the mitochondrial apoptotic pathway and activates caspase-3, which in turn processes caspase-6 and GSDME to trigger pyroptosis [PMID:11081635, PMID:11085743, PMID:8900201, PMID:32188940]. GzmB also directly cleaves nuclear substrates DNA-PKcs and NuMA independently of caspases and remodels extracellular matrix by cleaving vitronectin, fibronectin, and laminin [PMID:9586635, PMID:15843372]. Cytosolic SERPINB9/PI-9 protects effector lymphocytes from misdirected GzmB, transcription is controlled by synergistic AP-1/CRE promoter elements, and post-transcriptional regulation by miR-27a* and ZFP36L1 tunes GzmB protein output in activated lymphocytes [PMID:8910377, PMID:8219227, PMID:21960590]."},"prefetch_data":{"uniprot":{"accession":"P10144","full_name":"Granzyme B","aliases":["C11","CTLA-1","Cathepsin G-like 1","CTSGL1","Cytotoxic T-lymphocyte proteinase 2","Lymphocyte protease","Fragmentin-2","Granzyme-2","Human lymphocyte protein","HLP","SECT","T-cell serine protease 1-3E"],"length_aa":247,"mass_kda":27.7,"function":"Abundant protease in the cytosolic granules of cytotoxic T-cells and NK-cells which activates caspase-independent pyroptosis when delivered into the target cell through the immunological synapse (PubMed:1985927, PubMed:3262682, PubMed:3263427). It cleaves after Asp (PubMed:1985927, PubMed:8258716). Once delivered into the target cell, acts by catalyzing cleavage of gasdermin-E (GSDME), releasing the pore-forming moiety of GSDME, thereby triggering pyroptosis and target cell death (PubMed:31953257, PubMed:32188940). Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -9 and -10 (CASP3, CASP9 and CASP10, respectively) to give rise to active enzymes mediating apoptosis (PubMed:9852092). Cleaves and activates CASP7 in response to bacterial infection, promoting plasma membrane repair (By similarity)","subcellular_location":"Secreted; Cytolytic granule","url":"https://www.uniprot.org/uniprotkb/P10144/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GZMB","classification":"Not Classified","n_dependent_lines":38,"n_total_lines":1208,"dependency_fraction":0.03145695364238411},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GZMB","total_profiled":1310},"omim":[{"mim_id":"613931","title":"TARGET OF EGR1; TOE1","url":"https://www.omim.org/entry/613931"},{"mim_id":"611550","title":"NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3","url":"https://www.omim.org/entry/611550"},{"mim_id":"611195","title":"JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1; JAKMIP1","url":"https://www.omim.org/entry/611195"},{"mim_id":"610872","title":"RING FINGER PROTEIN 19B; RNF19B","url":"https://www.omim.org/entry/610872"},{"mim_id":"610379","title":"WEST NILE VIRUS, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/610379"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Calyx","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":62.9},{"tissue":"lung","ntpm":15.7},{"tissue":"lymphoid tissue","ntpm":33.8},{"tissue":"urinary bladder","ntpm":17.2}],"url":"https://www.proteinatlas.org/search/GZMB"},"hgnc":{"alias_symbol":["CCPI","CGL-1","CSP-B","CGL1","CTSGL1","HLP","SECT"],"prev_symbol":["CTLA1","CSPB"]},"alphafold":{"accession":"P10144","domains":[{"cath_id":"2.40.10.10","chopping":"34-127_238-247","consensus_level":"medium","plddt":97.2791,"start":34,"end":247},{"cath_id":"2.40.10.10","chopping":"141-235","consensus_level":"medium","plddt":95.8773,"start":141,"end":235}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P10144","model_url":"https://alphafold.ebi.ac.uk/files/AF-P10144-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P10144-F1-predicted_aligned_error_v6.png","plddt_mean":92.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GZMB","jax_strain_url":"https://www.jax.org/strain/search?query=GZMB"},"sequence":{"accession":"P10144","fasta_url":"https://rest.uniprot.org/uniprotkb/P10144.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P10144/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P10144"}},"corpus_meta":[{"pmid":"37963457","id":"PMC_37963457","title":"Single-cell atlas of healthy human blood unveils age-related loss of NKG2C+GZMB-CD8+ memory T cells and accumulation of type 2 memory T cells.","date":"2023","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/37963457","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21960590","id":"PMC_21960590","title":"Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21960590","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11500134","id":"PMC_11500134","title":"Production of delayed death and neoplastic transformation in CGL1 cells by radiation-induced bystander effects.","date":"2001","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/11500134","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24248158","id":"PMC_24248158","title":"Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis.","date":"2013","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/24248158","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3264185","id":"PMC_3264185","title":"Organization of two genes encoding cytotoxic T lymphocyte-specific serine proteases CCPI and CCPII.","date":"1988","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3264185","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14551783","id":"PMC_14551783","title":"Re-evaluation of the RBE of 29 kV x-rays (mammography x-rays) relative to 220 kV x-rays using neoplastic transformation of human CGL1-hybrid cells.","date":"2003","source":"Radiation and environmental biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/14551783","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26166761","id":"PMC_26166761","title":"Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection.","date":"2015","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26166761","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1761544","id":"PMC_1761544","title":"The 5'-flanking region of the human CGL-1/granzyme B gene targets expression of a reporter gene to activated T-lymphocytes in transgenic mice.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1761544","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2233710","id":"PMC_2233710","title":"Transcriptional activation of the human cytotoxic serine protease gene CSP-B in T lymphocytes.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2233710","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8219227","id":"PMC_8219227","title":"Consensus AP-1 and CRE motifs upstream from the human cytotoxic serine protease B (CSP-B/CGL-1) gene synergize to activate transcription.","date":"1993","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8219227","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27756896","id":"PMC_27756896","title":"A rare subset of skin-tropic regulatory T cells expressing Il10/Gzmb inhibits the cutaneous immune response.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27756896","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30487794","id":"PMC_30487794","title":"The miRNA 361-3p, a Regulator of GZMB and TNF Is Associated With Therapeutic Failure and Longer Time Healing of Cutaneous Leishmaniasis Caused by L. (viannia) braziliensis.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30487794","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33898319","id":"PMC_33898319","title":"Long Non-coding RNA LINC02474 Affects Metastasis and Apoptosis of Colorectal Cancer by Inhibiting the Expression of GZMB.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33898319","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30158536","id":"PMC_30158536","title":"Genetic polymorphisms of GZMB and vitiligo: A genetic association study based on Chinese Han population.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30158536","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29669300","id":"PMC_29669300","title":"RETRACTED: GZMB gene silencing confers protection against synovial tissue hyperplasia and articular cartilage tissue injury in rheumatoid arthritis through the MAPK signaling pathway.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29669300","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28265282","id":"PMC_28265282","title":"Fine-Mapping and Analysis of Cgl1, a Gene Conferring Glossy Trait in Cabbage (Brassica oleracea L. var. capitata).","date":"2017","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/28265282","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36157881","id":"PMC_36157881","title":"Decreased GZMB, NRP1, ITPR1, and SERPINB9 Transcripts Lead to Reduced Regulatory T Cells Suppressive Capacity in Generalized Vitiligo Patients.","date":"2022","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/36157881","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23321921","id":"PMC_23321921","title":"Risk of generalized vitiligo is associated with the common 55R-94A-247H variant haplotype of GZMB (encoding granzyme B).","date":"2013","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23321921","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37531918","id":"PMC_37531918","title":"Exploring the molecular mechanisms of the involvement of GZMB-Caspase-3-GSDME pathway in the progression of rheumatoid arthritis.","date":"2023","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37531918","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15913393","id":"PMC_15913393","title":"A radiation-induced acute apoptosis involving TP53 and BAX precedes the delayed apoptosis and neoplastic transformation of CGL1 human hybrid cells.","date":"2005","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/15913393","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33431938","id":"PMC_33431938","title":"Association of GZMB polymorphisms and susceptibility to non-segmental vitiligo in a Korean population.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33431938","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28873027","id":"PMC_28873027","title":"The CGL1 (HeLa × Normal Skin Fibroblast) Human Hybrid Cell Line: A History of Ionizing Radiation Induced Effects on Neoplastic Transformation and Novel Future Directions in SNOLAB.","date":"2017","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/28873027","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10792009","id":"PMC_10792009","title":"Loss of chromosome 14 increases the radiosensitivity of CGL1 human hybrid cells but lowers their susceptibility to radiation-induced neoplastic transformation.","date":"2000","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/10792009","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34517158","id":"PMC_34517158","title":"Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer: AuNPs-si-SP1 regulates GZMB for radiosensitivity.","date":"2021","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34517158","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28653095","id":"PMC_28653095","title":"QPY/RAH haplotypes of the GZMB gene are associated with natural killer cell cytotoxicity.","date":"2017","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/28653095","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31580949","id":"PMC_31580949","title":"Transcriptomic profiling of gamma ray induced mutants from the CGL1 human hybrid cell system reveals novel insights into the mechanisms of radiation-induced carcinogenesis.","date":"2019","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31580949","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19838298","id":"PMC_19838298","title":"Caspase-dependent inhibition of mousepox replication by gzmB.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19838298","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38607279","id":"PMC_38607279","title":"Disruption of IFNγ, GZMB, PRF1, or LYST Results in Reduced Suppressive Function in Human CD8+ T Cells.","date":"2024","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/38607279","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35621492","id":"PMC_35621492","title":"Identification of Radiation-Induced miRNA Biomarkers Using the CGL1 Cell Model System.","date":"2022","source":"Bioengineering (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35621492","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35460379","id":"PMC_35460379","title":"Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.","date":"2022","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/35460379","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37141110","id":"PMC_37141110","title":"Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo.","date":"2023","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/37141110","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39053388","id":"PMC_39053388","title":"Characteristics and functions of an atypical inflammation-associated GZMK+GZMB+CD8+ T subset in people living with HIV-1.","date":"2024","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39053388","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40169283","id":"PMC_40169283","title":"Targeting PD-1 and CD85j can restore intratumoral CD4+ GzmB+ T-cell functions to combat MHC-II-expressing tumors.","date":"2025","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40169283","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33994508","id":"PMC_33994508","title":"MiR-518a-5p Targets GZMB to Extenuate Vascular Endothelial Cell Injury Induced by Hypoxia-Reoxygenation and Thereby Improves Myocardial Ischemia.","date":"2021","source":"International heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/33994508","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39326683","id":"PMC_39326683","title":"Inhibition of GZMB activity ameliorates cognitive dysfunction by reducing demyelination in diabetic mice.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39326683","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33662167","id":"PMC_33662167","title":"Identification of CD56dim subpopulation marked with high expression of GZMB/PRF1/PI-9 in CD56+ interferon-α-induced dendritic cells.","date":"2021","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/33662167","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35733327","id":"PMC_35733327","title":"Expression of the GZMB Gene Polymorphism, SNP rs8192917, in 990 Han Chinese Patients with Postoperative Keloids.","date":"2022","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/35733327","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36613681","id":"PMC_36613681","title":"Coprinopsis cinerea Galectin CGL1 Induces Apoptosis and Inhibits Tumor Growth in Colorectal Cancer Cells.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36613681","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40979296","id":"PMC_40979296","title":"Single-cell profiling reveals immunoregulation of artemisinin on CD8+GZMB+ T cells via JAK2-STAT3 in malaria-infected mice.","date":"2025","source":"Innovation (Cambridge (Mass.))","url":"https://pubmed.ncbi.nlm.nih.gov/40979296","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36107603","id":"PMC_36107603","title":"Tuberculosis infection related hemophagocytic lymphohistiocytosis diagnosed in patient with GZMB mutation: A case report and literature review.","date":"2022","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36107603","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36890824","id":"PMC_36890824","title":"A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36890824","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39134062","id":"PMC_39134062","title":"The Role of Natural Background Radiation in Maintaining Genomic Stability in the CGL1 Human Hybrid Model System.","date":"2024","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/39134062","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36072399","id":"PMC_36072399","title":"Influences of miR-378a-3p on the Pathogenesis of Allergic Rhinitis via GzmB-Mediated Inflammatory Reaction.","date":"2022","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/36072399","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40414318","id":"PMC_40414318","title":"CXCL8 and GZMB genes promote cartilaginous and synovial lesion formation via NF-κB and MAPK signaling pathways in Kaschin-Beck disease.","date":"2025","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/40414318","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38791196","id":"PMC_38791196","title":"Immune Rejection Mediated by prf1 and gzmb Affects the Colonization of Fat Greenling (Hexagrammos otakii) Spermatogonia in Heterotransplantation.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38791196","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41378763","id":"PMC_41378763","title":"NK cell-derived GZMB (granzyme B) suppresses glioblastoma radioresistance by blocking SDC1-mediated autophagosome maturation.","date":"2026","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/41378763","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40510365","id":"PMC_40510365","title":"SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40510365","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37793172","id":"PMC_37793172","title":"Mannose oligosaccharide recognition of CGL1, a mannose-specific lectin containing DM9 motifs from Crassostrea gigas, revealed by X-ray crystallographic analysis.","date":"2023","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37793172","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41869345","id":"PMC_41869345","title":"The transcription factor ZNF683 marks an exhaustion-like GZMB+CD8+ T cell in sepsis.","date":"2026","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41869345","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.09.675154","title":"A post-transcriptional regulatory checkpoint controls the response of tumor-infiltrating cytotoxic CD4<sup>+</sup> T cells to immunotherapy","date":"2025-09-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.09.675154","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.31.25335414","title":"Developing an Early Diagnostic Signature and Deciphering the Microbial-Host Dynamics in Lower Respiratory Tract Infection (LRTI) in Paediatric Intensive Care Unit (PICU) Patients","date":"2025-11-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.31.25335414","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.14.654011","title":"Intraepithelial lymphocytes exhibit selective immunity to intestinal pathogens","date":"2025-05-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.14.654011","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.16.682832","title":"Decoding the human PBMC isonome: Isoform-level resolution with single-cell long-read transcriptomics","date":"2025-10-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.16.682832","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.21.683143","title":"Regulatory T cells inhibit CD8  <sup>+</sup>  T  <sub>RM</sub>  -like cells during the early stages of tumor immune escape","date":"2025-10-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.21.683143","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.22.683714","title":"Epithelial-Mesenchymal Transition is Associated with Altered Immune Composition and Cytotoxic Function in Triple-Negative Breast Cancer","date":"2025-10-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.22.683714","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.13.643086","title":"Granzyme-targeting quenched activity-based probes for assessing tumor response to immunotherapy","date":"2025-03-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.13.643086","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.11.10.687675","title":"Isolation of functional supramolecular attack particles (SMAPs)","date":"2025-11-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.10.687675","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.01.25332809","title":"Advancing Non-Invasive Respiratory Diagnostics: Multiplex Nasal Biomarker Profiling for Stratification of Airway Inflammatory Diseases","date":"2025-08-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.01.25332809","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.06.668764","title":"Angiogenic CD8 T cells from PWH induce Granzymes-dependent PAR1 activation promoting endothelial inflammation","date":"2025-08-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.06.668764","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.12.669857","title":"Immune dysregulation in the prostates of C57BL/6<sup>Aire-/-</sup>mice mirrors that seen in human benign prostatic hyperplasia","date":"2025-08-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.12.669857","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.29.635520","title":"Lytic IFNγ is stored in granzyme B-containing cytotoxic granules and co-secreted by effector CD8⁺ T cells","date":"2025-02-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.29.635520","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.12.27.630514","title":"Conditional fusogenic lipid nanocarriers for cytosolic delivery of  macromolecular therapeutics","date":"2024-12-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.27.630514","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.16.649085","title":"Multi-cellular phenotypic dynamics during the progression of breast tumors","date":"2025-04-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.16.649085","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.01.651731","title":"Enhancement of activation-induced T cell proliferation by SIRPG in a CD47-independent manner","date":"2025-05-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.01.651731","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.25.644515","title":"Comprehensive longitudinal profiling of SARS-CoV-2-specific CD8<sup>+</sup>T-cells reveal strong functional impairment and recognition bias as markers for disease severity","date":"2025-03-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.25.644515","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.05.636622","title":"NKG7 is a stable marker of cytotoxicity across immune contexts and within the tumor microenvironment","date":"2025-02-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.05.636622","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.18.649623","title":"CXCL13/CXCR5 Chemokine Axis Promotes CXCR5<sup>+</sup>CD19<sup>+</sup>B-Cell and Follicular/Effector CXCR5<sup>+</sup>CD4<sup>+</sup>T-Cell Responses in the Lungs Associated with Protection from Severe and Fatal COVID-19 Following Infection with Pathogenic SARS-CoV-2 Delta Variant","date":"2025-04-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.18.649623","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"9337844","id":"PMC_9337844","title":"Caspases: the executioners of apoptosis.","date":"1997","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9337844","citation_count":3881,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9727491","id":"PMC_9727491","title":"Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9727491","citation_count":2970,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32188940","id":"PMC_32188940","title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32188940","citation_count":1315,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15302935","id":"PMC_15302935","title":"Large-scale characterization of HeLa cell nuclear phosphoproteins.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15302935","citation_count":1159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9651578","id":"PMC_9651578","title":"Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization.","date":"1998","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/9651578","citation_count":954,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31953257","id":"PMC_31953257","title":"Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31953257","citation_count":469,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15238416","id":"PMC_15238416","title":"Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15238416","citation_count":391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15650747","id":"PMC_15650747","title":"XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15650747","citation_count":320,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20410501","id":"PMC_20410501","title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.","date":"2010","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20410501","citation_count":304,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11085743","id":"PMC_11085743","title":"Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.","date":"2000","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11085743","citation_count":300,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11081635","id":"PMC_11081635","title":"Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11081635","citation_count":295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20530211","id":"PMC_20530211","title":"Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair.","date":"2010","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20530211","citation_count":290,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24101526","id":"PMC_24101526","title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24101526","citation_count":277,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9586635","id":"PMC_9586635","title":"Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9586635","citation_count":272,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8900201","id":"PMC_8900201","title":"The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8900201","citation_count":268,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28461564","id":"PMC_28461564","title":"Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28461564","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8910377","id":"PMC_8910377","title":"A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8910377","citation_count":254,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23898208","id":"PMC_23898208","title":"Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23898208","citation_count":235,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2953813","id":"PMC_2953813","title":"Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes.","date":"1987","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2953813","citation_count":229,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17703412","id":"PMC_17703412","title":"Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.","date":"2007","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17703412","citation_count":223,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12200377","id":"PMC_12200377","title":"CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12200377","citation_count":219,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15843372","id":"PMC_15843372","title":"Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15843372","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14499262","id":"PMC_14499262","title":"Granzyme B: pro-apoptotic, antiviral and antitumor functions.","date":"2003","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14499262","citation_count":214,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12524539","id":"PMC_12524539","title":"Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A.","date":"2003","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12524539","citation_count":210,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11911826","id":"PMC_11911826","title":"Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11911826","citation_count":208,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23377437","id":"PMC_23377437","title":"Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23377437","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11266473","id":"PMC_11266473","title":"Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11266473","citation_count":206,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":37292,"output_tokens":4457,"usd":0.089366},"stage2":{"model":"claude-opus-4-6","input_tokens":7990,"output_tokens":2710,"usd":0.16155},"total_usd":0.629821,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":50514,"output_tokens":8863,"usd":0.142243},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12520,"output_tokens":3807,"usd":0.236662}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"GZMB (CGL-1/CCPI/CSP-B) encodes a cytotoxic T lymphocyte-specific serine protease whose gene organization places each active-site residue on a separate exon, with two unusual introns: one within the activation dipeptide and one interrupting the invariant core region near the active-site Asp, defining GZMB as part of a new subfamily of serine protease genes.\",\n      \"method\": \"Gene isolation, sequencing, and structural analysis of coding/noncoding regions\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct gene sequencing with structural validation; foundational paper\",\n      \"pmids\": [\"3264185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Transcriptional activation of the GZMB (CSP-B) gene in T lymphocytes requires synergistic signals from TPA and cAMP (bt2cAMP), is accompanied by formation of a DNase I-hypersensitive site upstream of the gene, and is driven by two regulatory regions at −609 to −202 and −202 to −80 that function as an upstream promoter element in an orientation-specific manner.\",\n      \"method\": \"Transient transfection of promoter-reporter constructs, DNase I hypersensitivity mapping, mRNA accumulation assays in PEER T-cell line\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (chromatin analysis, promoter deletion constructs) in a single study\",\n      \"pmids\": [\"2233710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The 5′-flanking regulatory sequences of the human GZMB (CSP-B/CGL-1) gene are sufficient to drive tissue-specific expression in activated T lymphocytes in vivo, responding to signals from the T-cell receptor (concanavalin A) or the IL-2 receptor (IL-2), with expression restricted to lymph nodes and small intestine at the organ level.\",\n      \"method\": \"Transgenic mouse reporter assay using CSP-B upstream sequences driving human growth hormone; T-cell activation with ConA and IL-2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with functional validation across multiple activation stimuli\",\n      \"pmids\": [\"1761544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Transcriptional activation of GZMB requires both a consensus AP-1 element and a consensus CRE located 5′ to the transcriptional start site; these elements act synergistically, with the AP-1 site being essential (single nucleotide substitutions abolish activity), and helical spacing between the two elements is critical for synergism, suggesting cooperative factor binding.\",\n      \"method\": \"Transient transfection of point-mutant and deletion promoter constructs into TPA+bt2cAMP-stimulated PEER cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis of regulatory elements with multiple independent constructs\",\n      \"pmids\": [\"8219227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Human miR-27a* negatively regulates NK-cell cytotoxicity by directly binding the 3′ UTRs of both Prf1 and GZMB mRNAs, down-regulating their protein expression in resting and activated NK cells; knockdown of miR-27a* dramatically increases NK cytotoxicity in vitro and decreases tumor growth in a xenograft model.\",\n      \"method\": \"3′ UTR luciferase reporter assay, miRNA knockdown/overexpression in primary NK cells, in vitro cytotoxicity assay, tumor xenograft model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct 3′UTR binding validated by reporter assay, functional knockdown with multiple readouts including in vivo\",\n      \"pmids\": [\"21960590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hypoxia-induced autophagy in breast cancer cells leads to selective autophagic degradation of NK-derived GZMB, thereby blocking NK-mediated apoptosis of tumor target cells; inhibiting autophagy restores susceptibility to NK killing and promotes tumor regression in vivo.\",\n      \"method\": \"Autophagy inhibition (genetic and pharmacological), NK co-culture cytotoxicity assay, in vivo tumor model with autophagy-targeted treatment\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway (autophagy degrades GZMB) established with multiple orthogonal methods and in vivo validation\",\n      \"pmids\": [\"24248158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GZMB-induced inhibition of ectromelia (mousepox) viral replication requires caspase-3/-7 activation; gzmB activates independent pro-apoptotic pathways (Bid/Bak/Bax and caspase-3/-7), and while ectromelia virus can partially block the Bid/Bak/Bax pathway, viral replication control is strictly dependent on the caspase-3/-7 pathway and strictly requires gzmB.\",\n      \"method\": \"Ex vivo immune Tc cells from GzmA-deficient and GzmAxB double-deficient mice co-cultured with ectromelia-infected targets; caspase-3/-7-deficient target cells; viral titer assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic epistasis using multiple knockout models combined with in vitro viral replication assay\",\n      \"pmids\": [\"19838298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-378 suppresses GZMB expression in NK cells; during dengue virus (DENV) infection, miR-378 is downregulated, allowing upregulation of GZMB in NK cells; overexpression of miR-378 using a miR-378 agomir in DENV-infected mice inhibited GZMB expression and promoted DENV replication, demonstrating that miR-378-regulated GZMB in NK cells is required for control of DENV infection.\",\n      \"method\": \"miRNA/mRNA expression profiling in patients, miR-378 agomir overexpression in vivo, viral replication assay\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — in vivo rescue experiment supports mechanism but 3′UTR direct binding not separately validated in this paper\",\n      \"pmids\": [\"26166761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Non-synonymous SNP rs8192917 (Q48R/Arg55Gln) in GZMB influences NK cell cytotoxicity; R48-GzmB accumulates to similar protein levels as Q48-GzmB in activated NK cells but differs in cytotoxic activity, indicating the polymorphism affects function rather than expression.\",\n      \"method\": \"Genotyping of Japanese donors, NK cell cytotoxicity assay, degranulation assay, GzmB protein quantification by flow cytometry\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional assay in primary cells correlating genotype with cytotoxic activity, single lab\",\n      \"pmids\": [\"28653095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-518a-5p directly binds the 3′ UTR of GZMB and negatively regulates GZMB expression; in a hypoxia/reoxygenation model of vascular endothelial cell injury, miR-518a-5p mimic enhanced cell proliferation and repressed apoptosis by inhibiting GZMB expression.\",\n      \"method\": \"TargetScan prediction, 3′UTR luciferase reporter assay, miRNA mimic overexpression, CCK-8 proliferation assay, Western blot\",\n      \"journal\": \"International heart journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — 3′UTR binding validated by reporter assay with functional follow-up, single lab\",\n      \"pmids\": [\"33994508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Knockout of GZMB (as well as PRF1, IFNγ, and LYST) in primary human CD8+ T cells using CRISPR-Cas9 significantly diminishes their in vitro immune suppressive ability, establishing that GZMB-mediated cytotoxicity is required for CD8+ T cell-mediated immune suppression.\",\n      \"method\": \"CRISPR-Cas9 gene knockout in primary human CD8+ T cells, qRT-PCR and flow cytometry knockout confirmation, in vitro T cell suppression assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with confirmed deletion and defined cellular phenotype (suppressive function)\",\n      \"pmids\": [\"38607279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TCF-1B (Tcf-1) expression in TCR-engineered CD8+ T cells prohibits acquisition of a GzmB-high state, protecting T cells from activation-induced cell death (fratricide/apoptosis) that occurs upon engagement with tumor cells, while promoting stem cell-like persistence.\",\n      \"method\": \"Constitutive TCF-1B expression in engineered CD8+ T cells, flow cytometry for GzmB, in vitro apoptosis assay, in vivo tumor xenograft model\",\n      \"journal\": \"Cancer immunology, immunotherapy : CII\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional link between Tcf-1 and GzmB state established in engineered cells with in vivo validation, single lab\",\n      \"pmids\": [\"35460379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GZMB activates caspase-3 and Gasdermin E (GSDME) to promote pyroptosis in rheumatoid arthritis synovial fibroblasts; silencing GZMB by siRNA reduces caspase-3 and GSDME cleavage, decreases LDH release, IL-1β and IL-18 levels, and reduces cell proliferation in HFLS-RA and MH7A cells.\",\n      \"method\": \"GZMB siRNA silencing, Western blot for caspase-3 and GSDME, LDH assay, ELISA for IL-1β/IL-18, CCK-8 and EDU proliferation assays in RA cell lines and rat model\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — pathway placement (GZMB→caspase-3→GSDME→pyroptosis) with multiple readouts, single lab\",\n      \"pmids\": [\"37531918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GZMB directly cleaves SDC1 (syndecan-1) at valine 225 and aspartate 228 sites, blocking autophagosome-lysosome fusion by obstructing the localization of TGM2 (a key LC3 recognizer) on the lysosome surface, thereby impairing autophagosome maturation and sensitizing glioblastoma cells to irradiation.\",\n      \"method\": \"Co-culture of NK cells with GBM cells, exogenous GZMB treatment, cleavage site mutagenesis (uncleavable SDC1 mutant), autophagy flux assays, in vitro and xenograft radiosensitization models, clinical data correlation\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct substrate identification with site mutagenesis, mechanistic follow-up with pathway placement, and in vivo validation\",\n      \"pmids\": [\"41378763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In tumor-infiltrating CD4+ T cells, Gzmb mRNA is abundantly transcribed but GzmB protein is post-transcriptionally restrained by the RNA-binding protein ZFP36L1 (and its paralog ZFP36); checkpoint blockade (anti-CTLA-4 or anti-LAG-3 + anti-PD-1) relieves this block by repressing ZFP36L1 expression, allowing GzmB protein production and CD4+ cytotoxic T cell anti-tumor activity.\",\n      \"method\": \"Genetic deletion of Zfp36l1/Zfp36, constitutive Zfp36l1 expression, anti-CTLA-4 and anti-PD-1/LAG-3 treatment in mouse tumor models, protein vs. mRNA quantification\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution/genetic gain and loss-of-function of the post-transcriptional regulator with multiple orthogonal approaches, strong mechanistic detail\",\n      \"pmids\": [\"bio_10.1101_2025.09.09.675154\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In activated CD8+ T cells, a subset of IFNγ is stored within GzmB-containing cytotoxic granules (termed 'lytic IFNγ') and co-secreted with GzmB at the immunological synapse in both soluble and SMAP-associated forms; impaired vesicle priming (Munc13-4 deficiency) reduces both CG and early IFNγ release, linking GzmB granule biology to IFNγ secretion.\",\n      \"method\": \"Super-resolution and live-cell imaging, Munc13-4 knockout mouse CD8+ T cells, co-secretion assay at immunological synapse, SMAP isolation\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct co-localization with functional validation in KO cells, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.01.29.635520\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Inhibition of GZMB proteolytic activity (by SerpinA3N inhibitor) in diabetic mice reduces endoplasmic reticulum stress and pyroptosis in hippocampal oligodendrocytes, decreases demyelination (measured by MBP, CNPase expression), and ameliorates cognitive dysfunction, placing GZMB upstream of the PERK/eIF2α ER stress pathway and NLRP3/caspase-1/GSDMD pyroptosis pathway in oligodendrocytes.\",\n      \"method\": \"Streptozotocin diabetic mouse model, SerpinA3N GZMB inhibitor treatment, Morris water maze, immunofluorescence, immunohistochemistry, Western blot for PERK, eIF2α, NLRP3, caspase-1, GSDMD-N, MBP, CNPase\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition with defined pathway readouts and behavioral phenotype, single lab\",\n      \"pmids\": [\"39326683\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GZMB encodes a cytotoxic serine protease constitutively expressed in CTLs and NK cells under the control of AP-1/CRE promoter elements and subject to post-transcriptional silencing by miRNAs (miR-27a*, miR-378) and RNA-binding proteins (ZFP36L1); once delivered into target cells (via perforin or SDC1-mediated autophagosome disruption), it cleaves substrates including caspase-3 and GSDME to trigger apoptosis or pyroptosis, activates independent Bid/Bak/Bax and caspase-3/-7 pathways to inhibit viral replication, and can also be degraded by autophagy in hypoxic tumor cells as an immune-escape mechanism; additionally, it is required for CD8+ T cell-mediated immune suppression and is stored in cytotoxic granules alongside IFNγ for polarized co-secretion at the immunological synapse.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify papers as KEEP or EXCLUDE, then extract mechanistic discoveries.\n\n**EXCLUDE papers (alias collisions/off-target):**\n- Papers about CGL1 radiation/neoplastic transformation (HeLa×fibroblast hybrid cell line) — these are cell line studies unrelated to GZMB protein function: PMIDs 11500134, 14551783, 15913393, 10792009, 28873027, 31580949, 37141110, 39134062, 35621492\n- CGL1 Brassica oleracea glossy gene: PMID 28265282\n- CGL1 Coprinopsis cinerea galectin: PMID 36613681\n- CGL1 Crassostrea gigas oyster lectin: PMID 37793172\n- Pure expression/biomarker/GWAS papers with no mechanism: PMIDs 37963457, 30158536, 23321921, 33431938, 35733327, 36890824, 30487794, 12477932, 15302935, 21873635, 15489334, 17703412\n- Papers about other genes where GZMB is mentioned only as a marker: PMIDs 9337844 (caspases general), 9727491 (Bid/Bcl2), 9651578 (caspase-9/Apaf-1), 15650747 (XIAP/caspase), 20410501 (vitiligo GWAS), 23898208 (HIV-Tat), 20530211 (acid sphingomyelinase), 12524539 (GzmA paper)\n- Retracted paper: PMID 29669300\n\n**KEEP**: Papers with direct mechanistic findings about GZMB protein.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"GZMB (clone 1-3E) encodes a 247-residue serine protease induced in mitogen-stimulated human T lymphocytes; its mRNA is expressed specifically in T lymphocyte clones and is most closely related (68% homology) to murine cytotoxic T lymphocyte protease CCPI.\",\n      \"method\": \"cDNA cloning and sequencing, Northern blot expression analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original molecular cloning with sequence identity and expression characterization\",\n      \"pmids\": [\"2953813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The GZMB gene (CCPII) shares a gene organization with other serine protease genes in which each active-site residue is on a separate exon; two introns occur at unique positions — one within the activation dipeptide and one interrupting the invariant core region near the active-site Asp — defining GZMB as a new subfamily of serine protease genes.\",\n      \"method\": \"Genomic cloning, sequencing, and gene structure analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct genomic sequencing establishing gene architecture and active-site exon organization\",\n      \"pmids\": [\"3264185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Transcriptional activation of CSP-B/GZMB in T lymphocytes requires synergistic action of TPA and cAMP (bt2cAMP); neither agent alone activates transcription. Upon activation, a DNase I-hypersensitive site forms upstream from the gene, and the region −615 to −63 functions as an orientation-specific upstream promoter element.\",\n      \"method\": \"Transient transfection of promoter-reporter constructs, DNase I hypersensitivity assay, Northern blot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — functional promoter mapping with mutagenesis and chromatin analysis, multiple methods\",\n      \"pmids\": [\"2233710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The 5′-flanking region of the human GZMB (CSP-B/CGL-1) gene is sufficient to drive expression specifically in activated T lymphocytes in vivo; expression is induced by ConA or IL-2 (but not in resting cells), responding to signals from both the TCR and the IL-2 receptor.\",\n      \"method\": \"Transgenic mouse reporter assay (human growth hormone driven by CSP-B promoter)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo promoter function established in multiple transgenic founder lines\",\n      \"pmids\": [\"1761544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A consensus AP-1 element and a consensus CRE located 5′ to the GZMB transcriptional start site both are required and synergize for transcriptional activation; the AP-1 site is dominant (replacement with a second AP-1 retains activity, but replacement with a CRE abolishes it); helical spacing between the two elements is critical, suggesting cooperative DNA-bound factor interactions.\",\n      \"method\": \"Transient transfection of promoter constructs with point mutations and deletions in PEER T cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic site-directed mutagenesis of promoter elements with functional readout\",\n      \"pmids\": [\"8219227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Proteinase inhibitor 9 (PI-9/SERPINB9) forms an SDS-resistant covalent complex with granzyme B with a second-order rate constant of 1.7×10⁶ M⁻¹s⁻¹, completely abrogates granzyme B– and perforin-mediated cytotoxicity in vitro, and is a cytosolic (not secreted) protein present in a separate subcellular compartment from granzyme B in NK cells — functioning as an endogenous inhibitor that protects cytotoxic lymphocytes from misdirected granzyme B.\",\n      \"method\": \"Recombinant protein production, serpin-protease complex assay, kinetic analysis, cytotoxicity assay, subcellular fractionation, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with kinetics, multiple orthogonal methods, functional validation\",\n      \"pmids\": [\"8910377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Granzyme B can process pro-Mch2alpha (caspase-6) and pro-Mch6 (caspase-14/caspase-9 homolog), but cleavage of pro-Mch2alpha by granzyme B alone is insufficient; granzyme B must first activate CPP32 (caspase-3), which then processes pro-Mch2alpha to generate active lamin-cleaving enzyme — establishing a protease cascade: granzyme B → caspase-3 → caspase-6/lamin cleavage.\",\n      \"method\": \"In vitro cleavage assays with recombinant proteins, site-directed mutagenesis, cell-free extract reconstitution\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis demonstrating cascade order\",\n      \"pmids\": [\"8900201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Granzyme B directly and efficiently cleaves downstream caspase substrates DNA-PKcs and NuMA in vitro and in vivo, generating cleavage fragments distinct from those produced by caspases, demonstrating a caspase-independent direct proteolytic execution pathway.\",\n      \"method\": \"In vitro cleavage assays, cell-free apoptosis system, immunoblot of cleavage products in CTL-treated cells\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and in vivo substrate cleavage with unique fragment identification\",\n      \"pmids\": [\"9586635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Granzyme B initiates apoptosis through the mitochondrial pathway by directly cleaving Bid; this Bid cleavage occurs upstream of and independently of mitochondrial Bcl-2, is not delayed by caspase inhibition, and is required (mutation of GrB cleavage site in Bid abolishes apoptosis restoration) — placing direct Bid cleavage as the essential upstream step in GrB-mediated mitochondrial pathway activation.\",\n      \"method\": \"Bcl-2-overexpressing cell lines, Bid mutants (cleavage site and BH3 domain mutations), granzyme B treatment with caspase inhibitors, flow cytometry of mitochondrial membrane potential\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with multiple Bid mutants, epistasis with Bcl-2, replicated in multiple cell models\",\n      \"pmids\": [\"11085743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The cation-independent mannose 6-phosphate receptor (CI-MPR/IGF2R) is identified as a cell-surface receptor for granzyme B; blocking this interaction prevents GrB binding, uptake, and apoptosis induction; CI-MPR expression is required for CTL-mediated apoptosis in vitro and for allogeneic cell rejection in vivo.\",\n      \"method\": \"Receptor blocking with antibodies/ligands, CI-MPR-deficient cells, in vitro cytotoxicity assay, in vivo allograft rejection model\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in vitro and in vivo, multiple blocking approaches, functional readouts\",\n      \"pmids\": [\"11081635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Rab27a, which colocalizes with granzyme B-positive secretory granules, is required for a late step in granule exocytosis; Rab27a-deficient (ashen) CTLs have normal perforin and granzyme A/B levels and normal granule polarization, but show >90% reduction in granule-mediated cytotoxicity and drastically defective rapid anti-CD3-induced granule secretion.\",\n      \"method\": \"Rab27a-deficient ashen mouse CTLs, granule polarization assay, cytotoxicity assay, granzyme secretion measurement, immunofluorescence colocalization\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO model with multiple functional assays, colocalization demonstrating Rab27a-GzmB granule association\",\n      \"pmids\": [\"11266473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Granzyme B and perforin co-exist as multimeric complexes with the proteoglycan serglycin in cytotoxic granules, and cytotoxic cells secrete exclusively macromolecular GrB-serglycin complexes; perforin mediates cytosolic delivery of these macromolecular GrB-serglycin complexes without producing detectable plasma membrane pores.\",\n      \"method\": \"Granule biochemistry, size-exclusion chromatography, ELISA, electron microscopy, membrane permeabilization assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution of GrB-serglycin complex with functional delivery assay\",\n      \"pmids\": [\"11911826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Granzyme B functions as a caspase-like serine protease released by cytotoxic lymphocytes; PI-9 (SERPINB9) regulates its function in lymphocytes; granzyme B can enter and traffic within target cells and triggers cell death through Bid cleavage and caspase activation.\",\n      \"method\": \"Review synthesizing biochemical and cell biological evidence from multiple primary studies\",\n      \"journal\": \"Current opinion in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — review of replicated mechanistic findings across multiple labs\",\n      \"pmids\": [\"14499262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Granzyme B is differentially expressed in human lymphocyte subsets: most CD56+CD8− NK cells and ~50% of CD8+ T cells co-express granzymes A and B; activation with ConA/IL-2 or anti-CD3/CD46 strongly induces granzyme B (but not A) in both CD8+ and CD4+ T cells; granzyme B-expressing CD4+ Tr1 cells kill target cells in a perforin-dependent, MHC/TCR-independent manner.\",\n      \"method\": \"Flow cytometry (intracellular staining), activation assays, perforin-dependent killing assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — comprehensive characterization across lymphocyte subsets with functional killing validation\",\n      \"pmids\": [\"15238416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Human granzyme B cleaves extracellular matrix proteins vitronectin (after an RGD motif), fibronectin, and laminin, causing cell detachment and anoikis of endothelial cells, and inhibiting tumor cell spreading, migration, and invasion — revealing a perforin-independent ECM remodeling activity of secreted granzyme B.\",\n      \"method\": \"In vitro cleavage assays with purified ECM proteins, cell detachment and anoikis assays, migration/invasion assays, cleavage site mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro substrate cleavage combined with multiple cell biological functional assays\",\n      \"pmids\": [\"15843372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Granzyme B-induced apoptosis of ectromelia-infected target cells is totally dependent on caspase-3/-7 (not Bid/Bak/Bax pathway); ectromelia virus can partially block GzmB-induced apoptosis when caspase-3/-7 is the only available pathway, but inhibition of viral replication in vitro was significantly reduced only in caspase-3/-7-deficient cells — establishing caspase-3/-7 as the critical pathway for GzmB-mediated viral control.\",\n      \"method\": \"Ex vivo immune Tc cells from GzmA-KO and GzmAxB-DKO mice, caspase-3/-7-deficient and Bid/Bak/Bax-deficient target cells, viral titer measurement, apoptosis assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO of multiple pathway components with physiological viral infection model\",\n      \"pmids\": [\"19838298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Human miR-27a* is a negative regulator of NK cell cytotoxicity by directly binding the 3′UTR of both Prf1 and GzmB mRNAs and down-regulating their expression in both resting and activated NK cells; knockdown of miR-27a* in NK cells dramatically increases cytotoxicity in vitro and decreases tumor growth in a xenograft model.\",\n      \"method\": \"3′UTR luciferase reporter assay, miRNA overexpression/knockdown, NK cell cytotoxicity assay, tumor xenograft model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct 3′UTR binding validated by reporter assay, functional in vitro and in vivo validation\",\n      \"pmids\": [\"21960590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hypoxia-induced autophagy in breast cancer cells causes selective degradation of NK-derived granzyme B in autophagosomes, blocking NK-mediated target cell apoptosis; inhibition of autophagy by targeting BECN1 restores granzyme B levels in hypoxic cells and induces tumor regression in vivo by facilitating NK killing.\",\n      \"method\": \"Autophagy inhibition (BECN1 knockdown), GrB immunofluorescence/colocalization with autophagosomes, NK cytotoxicity assay, in vivo tumor regression model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway (autophagosomal degradation) with in vitro and in vivo validation\",\n      \"pmids\": [\"24101526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hypoxia-induced autophagy impairs breast cancer cell susceptibility to NK-mediated lysis by selectively degrading GZMB in autophagosomes of hypoxic cells, thereby blocking NK-mediated apoptosis; targeting autophagy reverses this and promotes tumor regression in vivo.\",\n      \"method\": \"Autophagy activation/inhibition, GZMB immunofluorescence, autophagosome-lysosome colocalization, NK cytotoxicity assay, in vivo xenograft\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replication of autophagosomal GZMB degradation mechanism from companion paper with additional functional data\",\n      \"pmids\": [\"24248158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Perforin forms transient pores on the target cell plasma membrane within 30 seconds of cytotoxic lymphocyte recognition, allowing rapid diffusion of extracellular granzymes into the synaptic cleft and entry into target cells; pore repair begins within 20 seconds and is complete within 80 seconds, yet this brief window is sufficient to deliver lethal granzyme B amounts triggering caspase-dependent apoptosis within 2 minutes.\",\n      \"method\": \"Time-lapse microscopy of human primary CTLs at immunological synapses, calcium flux assays, pore kinetics, caspase activity monitoring\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct real-time imaging of physiological synapse with quantitative kinetic measurements\",\n      \"pmids\": [\"23377437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-378 (but not miR-27a* or miR-30e) suppresses GzmB expression in NK cells during dengue virus infection; overexpression of miR-378 in DENV-infected mice inhibited GzmB expression and promoted DENV replication, establishing miR-378 as a critical regulator of GzmB-mediated NK cell control of viral infection.\",\n      \"method\": \"miRNA agomir overexpression in vivo, GzmB expression measurement (flow cytometry), viral titer measurement in infected mice\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo functional validation but no direct 3′UTR binding assay reported for miR-378/GzmB\",\n      \"pmids\": [\"26166761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"QPY/RAH polymorphism (rs8192917; Q48R) in the GZMB gene influences NK cell cytotoxicity; R48-GzmB accumulates to similar levels as Q48-GzmB in activated NK cells but NK cell cytotoxicity is significantly influenced by this non-synonymous SNP, suggesting the R48 variant alters functional activity rather than protein stability.\",\n      \"method\": \"Genotyping of NK cell donors, NK cytotoxicity assay (51Cr release), GzmB protein quantification by flow cytometry/ELISA, degranulation assay\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional NK cell assays correlating genotype with cytotoxic activity, single study\",\n      \"pmids\": [\"28653095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Granzyme B directly cleaves GSDME (Gasdermin E) at the same site as caspase-3, converting apoptosis to pyroptosis in target cells; GSDME-mediated pyroptosis triggered by killer cell granzyme B enhances anti-tumor immunity through increased phagocytosis by macrophages and augmented NK and CD8+ T cell tumor infiltration; uncleavable or pore-defective GSDME abolishes tumor suppression.\",\n      \"method\": \"In vitro GrB cleavage assay with recombinant GSDME, GSDME knockout/knockin mice, perforin-deficient mice, lymphocyte depletion, tumor growth assays, macrophage phagocytosis assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of direct cleavage, multiple genetic KO models, replicated with multiple orthogonal approaches\",\n      \"pmids\": [\"32188940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CAR T cell-released granzyme B cleaves GSDME in target (B leukemic) cells, activating caspase 3-dependent pyroptosis; pyroptosis-released factors then activate caspase 1 for GSDMD cleavage in macrophages, triggering cytokine release syndrome (CRS); GSDME knockout or macrophage depletion eliminates CRS in mouse models.\",\n      \"method\": \"GSDME knockout target cells, macrophage depletion, caspase 1 inhibition, CAR T cell co-culture, CRS mouse model, GrB quantification\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic KO models establishing GrB→GSDME→macrophage CRS cascade\",\n      \"pmids\": [\"31953257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The transcription factor SP1 represses GZMB expression in lung cancer cells; inhibiting SP1 (via AuNPs-siRNA-SP1) upregulates GZMB, promotes G2/M arrest, increases DNA double-strand breaks, and enhances radiosensitivity both in vitro and in vivo.\",\n      \"method\": \"SP1 siRNA knockdown, Western blot, RT-qPCR, colony formation assay, flow cytometry cell cycle and apoptosis, immunofluorescence (γH2AX), xenograft tumor model\",\n      \"journal\": \"Translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — SP1-GZMB regulatory axis established by knockdown with multiple functional readouts, single lab\",\n      \"pmids\": [\"34517158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Tcf-1B expression in CD8+ T cells prohibits acquisition of a GzmB-high state during effector differentiation, protecting TCR-engineered T cells from activation-induced cell death (fratricidal GzmB-mediated apoptosis) and promoting stem cell-like persistence.\",\n      \"method\": \"Constitutive Tcf-1B expression in CD8+ T cells, flow cytometry of GzmB expression, apoptosis assays, in vitro anti-tumor activity, in vivo xenograft model\",\n      \"journal\": \"Cancer immunology, immunotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct manipulation of Tcf-1B with GzmB phenotypic readout, in vitro and in vivo, single lab\",\n      \"pmids\": [\"35460379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GZMB activates the caspase-3–GSDME (Gasdermin E) pyroptosis pathway in rheumatoid arthritis synovial cells; GZMB silencing reduces caspase-3 and GSDME activation, decreases pyroptosis markers (LDH, IL-1β, IL-18), and reduces cell proliferation in HFLS-RA and MH7A cells.\",\n      \"method\": \"GZMB siRNA knockdown, CCK8 and EDU proliferation assays, LDH assay, ELISA (IL-1β, IL-18), Western blot of GZMB/caspase-3/GSDME\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with multiple pathway readouts, single lab\",\n      \"pmids\": [\"37531918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GZMB inhibition (by SerpinA3N) in diabetic mice reduces endoplasmic reticulum stress (PERK/eIF2α pathway) and pyroptosis (NLRP3/caspase-1/GSDMD-N/IL-1β/IL-18) in hippocampal oligodendrocytes, reduces demyelination (restores MBP and CNPase expression), and ameliorates cognitive dysfunction — establishing GZMB as a promoter of oligodendrocyte ER stress and pyroptosis leading to demyelination.\",\n      \"method\": \"Streptozotocin diabetic mouse model, SerpinA3N (GZMB inhibitor) treatment, Morris water maze, immunofluorescence, Luxol Fast Blue staining, electron microscopy, Western blot\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition of GZMB with multiple pathway readouts in vivo, single lab\",\n      \"pmids\": [\"39326683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CRISPR-Cas9 knockout of GZMB (alongside PRF1, LYST, or IFNγ) in primary human CD8+ T cells significantly diminishes their in vitro immune suppressive ability, establishing that GZMB is required for CD8+ T cell-mediated immune suppression.\",\n      \"method\": \"CRISPR-Cas9 RNP knockout in primary human CD8+ T cells, RT-qPCR and flow cytometry confirmation of KO, in vitro T cell suppression assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean CRISPR KO in primary human cells with specific functional suppression readout\",\n      \"pmids\": [\"38607279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"NK cell-derived GZMB suppresses glioblastoma radioresistance by directly cleaving SDC1 (syndecan-1) at valine-225 and aspartate-228 sites, blocking autophagosome-lysosome fusion; SDC1 cleavage disrupts TGM2 localization on the lysosome surface (a key LC3 recognizer), impairing autophagosome maturation and thereby radiosensitizing GBM cells.\",\n      \"method\": \"Co-culture NK/GBM experiments, GZMB activity inhibition, exogenous recombinant GZMB, in vitro cleavage assay identifying SDC1 cleavage sites, uncleavable SDC1 mutant rescue experiment, TGM2 lysosome localization assay, xenograft model, clinical data correlation\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct substrate cleavage site identified, uncleavable mutant reversal, multiple functional assays, in vivo validation\",\n      \"pmids\": [\"41378763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In CD4+ cytotoxic T cells (TCTX) in untreated tumors, Gzmb mRNA is abundant but Granzyme B protein is limited (poised state); anti-CTLA-4 or anti-LAG-3+anti-PD-1 treatment removes this post-transcriptional block by repressing the RNA-binding protein Zfp36l1; constitutive Zfp36l1 expression abrogates anti-CTLA-4 effects on GzmB protein, while deletion of Zfp36l1 and its paralog Zfp36 triggers GzmB protein production and promotes tumor control.\",\n      \"method\": \"Zfp36l1 constitutive expression and genetic deletion, anti-CTLA-4/anti-LAG-3+PD-1 treatment, GzmB protein vs. mRNA quantification, tumor growth assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic gain/loss-of-function with mechanistic pathway placement, preprint pending peer review\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"IFNγ is stored within GzmB+ cytotoxic granules in activated mouse and human CD8+ T cells ('lytic IFNγ') and is co-secreted with GzmB at the immunological synapse; Munc13-4-deficient T cells show impaired both cytotoxic granule and early IFNγ release at the synapse, linking GzmB granule exocytosis machinery to IFNγ secretion.\",\n      \"method\": \"Super-resolution imaging, Munc13-4 KO T cells, time-lapse microscopy of immunological synapses, granule-IFNγ colocalization, SMAP isolation\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct co-localization with genetic KO confirmation, preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Granzyme-targeting quenched activity-based probe Cy5-IEPCya(Ph)P-QSY21 reacts rapidly with GzmB at substoichiometric concentrations and enables selective labeling of the active enzyme in complex proteomes; in vivo fluorescence signals correlate with GzmB expression/activity and CD8+ cell density in tumor tissues.\",\n      \"method\": \"Activity-based probe synthesis, in vitro selectivity assays, in vivo optical imaging in immunotherapy-treated mice, ex vivo correlation with GzmB expression\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct active-site probe with functional validation in vivo, preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Supramolecular attack particles (SMAPs) enriched from NK-92 cell cultures contain GZMB and PRF1 as core cytotoxic components; Ca2+-stabilized SMAPs trigger caspase-3-dependent apoptosis in tumor cell lines in a dose-dependent manner, and restrain tumor growth in NSG mice bearing B16F10 melanoma and PANC-1 pancreatic cancer.\",\n      \"method\": \"Serial size-exclusion chromatography SMAP isolation, proteomics, nano flow cytometry, TEM, TIRFM, caspase-3 apoptosis assay, NSG mouse xenograft models\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical characterization of GZMB-containing particles with functional caspase-dependent cytotoxicity validation, preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"GZMB encodes a caspase-like serine protease stored with perforin and serglycin in cytotoxic granules of CTLs and NK cells; upon immunological synapse formation, perforin transiently permeabilizes the target cell plasma membrane allowing GzmB entry (facilitated by CI-MPR/IGF2R receptor-mediated uptake), whereupon GzmB initiates apoptosis primarily by directly cleaving Bid to activate the mitochondrial pathway and by activating caspase-3 (which cleaves downstream substrates including GSDME to trigger pyroptosis), can also directly cleave caspase substrates (DNA-PKcs, NuMA) in a caspase-independent manner, remodels ECM by cleaving vitronectin/fibronectin/laminin, and blocks autophagosome maturation by cleaving SDC1; its expression is transcriptionally controlled by AP-1/CRE promoter elements and post-transcriptionally regulated by miR-27a* and ZFP36L1, while cytosolic SERPINB9/PI-9 protects cytotoxic lymphocytes from self-inflicted GzmB damage, and Rab27a is required for GzmB-containing granule exocytosis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GZMB encodes a cytotoxic serine protease expressed in CTLs and NK cells that is a central effector of granule-mediated target cell killing, antiviral defense, and immune regulation. Transcription requires synergistic AP-1 and CRE promoter elements activated by TCR or IL-2 receptor signaling [PMID:8219227, PMID:1761544], while post-transcriptional control is exerted by multiple miRNAs (miR-27a*, miR-378, miR-518a-5p) and the RNA-binding protein ZFP36L1 that restrains GZMB protein in tumor-infiltrating CD4+ T cells until checkpoint blockade relieves this block [PMID:21960590, PMID:26166761]. Once delivered to target cells, GZMB activates independent Bid/Bak/Bax and caspase-3/-7 apoptotic pathways essential for viral replication control [PMID:19838298], cleaves GSDME to induce pyroptosis [PMID:37531918], and cleaves SDC1 to disrupt autophagosome–lysosome fusion, sensitizing glioblastoma to irradiation [PMID:41378763]. GZMB-mediated cytotoxicity is also required for CD8+ T cell immune suppressive function [PMID:38607279], and hypoxic tumor cells can evade NK killing through autophagic degradation of delivered GZMB [PMID:24248158].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Establishing that GZMB encodes a serine protease with a novel gene organization — each catalytic triad residue on a separate exon — defined it as the founding member of a distinct serine protease subfamily in cytotoxic lymphocytes.\",\n      \"evidence\": \"Gene isolation, sequencing, and exon–intron structural analysis\",\n      \"pmids\": [\"3264185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic activity and substrate specificity not yet demonstrated\", \"No crystal structure available\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Mapping the transcriptional regulation of GZMB showed that synergistic AP-1 and CRE promoter elements, activated by TPA/cAMP signaling or by TCR/IL-2R engagement, drive tissue-specific expression restricted to activated T lymphocytes in vivo.\",\n      \"evidence\": \"Promoter-reporter constructs with point mutations in PEER cells; transgenic mouse reporter driven by 5′ flanking sequences\",\n      \"pmids\": [\"2233710\", \"1761544\", \"8219227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin remodeling factors recruited to the promoter not identified\", \"Regulation in NK cells not separately addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that GZMB activates independent Bid/Bak/Bax and caspase-3/-7 pro-apoptotic pathways — and that antiviral replication control strictly depends on the caspase-3/-7 arm — resolved how GZMB kills virally infected cells even when one apoptotic pathway is blocked by viral inhibitors.\",\n      \"evidence\": \"Genetic epistasis using GzmA/GzmB double-KO and caspase-3/-7-deficient target cells with ectromelia virus replication assays\",\n      \"pmids\": [\"19838298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cleavage sites on viral substrates not mapped\", \"Whether other granzymes compensate in vivo not fully resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of miR-27a* as a direct post-transcriptional repressor of GZMB (and perforin) in NK cells established that miRNA-mediated silencing tunes cytotoxic effector output, with knockdown enhancing tumor rejection in vivo.\",\n      \"evidence\": \"3′ UTR luciferase reporter, miRNA knockdown/overexpression in primary NK cells, xenograft tumor model\",\n      \"pmids\": [\"21960590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signals regulating miR-27a* levels not defined\", \"Whether miR-27a* operates similarly in CTLs unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showing that hypoxic tumor cells selectively degrade NK-delivered GZMB via autophagy revealed a tumor immune-evasion mechanism, as autophagy inhibition restored NK-mediated killing.\",\n      \"evidence\": \"Genetic and pharmacological autophagy inhibition, NK co-culture cytotoxicity assays, in vivo breast cancer model\",\n      \"pmids\": [\"24248158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Autophagy receptor recognizing GZMB not identified\", \"Whether this mechanism extends to CTL-delivered GZMB not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"miR-378 was identified as a second miRNA repressor of GZMB in NK cells; its downregulation during dengue virus infection permits GZMB upregulation required for viral control.\",\n      \"evidence\": \"miRNA profiling in patients, miR-378 agomir in vivo, viral titer assays\",\n      \"pmids\": [\"26166761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct 3′ UTR binding of miR-378 to GZMB not validated by reporter assay in this study\", \"Contribution of other GZMB-targeting miRNAs during DENV infection not assessed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CRISPR-Cas9 knockout of GZMB in primary human CD8+ T cells diminished their suppressive function, establishing GZMB-dependent cytotoxicity as a requirement for CD8+ T cell-mediated immune suppression.\",\n      \"evidence\": \"CRISPR-Cas9 KO in primary human CD8+ T cells with in vitro suppression assays\",\n      \"pmids\": [\"38607279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target cell identity in suppression assay not fully defined\", \"Whether perforin pathway or alternative delivery is used not dissected\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"GZMB was placed upstream of caspase-3/GSDME-mediated pyroptosis in rheumatoid arthritis synovial fibroblasts, expanding its effector repertoire beyond classical apoptosis to include inflammatory cell death.\",\n      \"evidence\": \"GZMB siRNA silencing, Western blot for caspase-3 and GSDME cleavage, LDH release, IL-1β/IL-18 ELISA in RA cell lines and rat model\",\n      \"pmids\": [\"37531918\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical cleavage of GSDME by GZMB-activated caspase-3 not reconstituted in vitro\", \"Source of GZMB (immune cells vs. autocrine) in RA synovium not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that GZMB directly cleaves SDC1 at V225/D228 to block autophagosome–lysosome fusion (by displacing TGM2) provided a new non-apoptotic mechanism by which GZMB sensitizes glioblastoma to radiation.\",\n      \"evidence\": \"Cleavage-site mutagenesis (uncleavable SDC1), autophagy flux assays, NK-GBM co-culture, xenograft radiosensitization\",\n      \"pmids\": [\"41378763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SDC1 cleavage occurs in non-GBM contexts unknown\", \"Structural basis for GZMB recognition of SDC1 not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Pharmacological inhibition of GZMB by SerpinA3N in diabetic mice reduced ER stress (PERK/eIF2α) and NLRP3/GSDMD-mediated pyroptosis in oligodendrocytes, linking GZMB activity to demyelination and cognitive dysfunction.\",\n      \"evidence\": \"SerpinA3N treatment in streptozotocin diabetic mice, behavioral testing, Western blot for pathway markers\",\n      \"pmids\": [\"39326683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GZMB's direct substrate in oligodendrocytes not identified\", \"Source of GZMB (infiltrating lymphocytes vs. local cells) in diabetic brain not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unifying structural and kinetic model explaining how GZMB selects among its diverse substrates (caspase-3, Bid, SDC1, GSDME pathway) in different cellular contexts — and how delivery route (perforin vs. alternative) determines substrate access — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No comprehensive substrate selectivity model integrating structural and cellular context data\", \"Relative contributions of perforin-dependent vs. perforin-independent GZMB delivery pathways not quantified\", \"Mechanisms by which ZFP36L1-mediated post-transcriptional silencing is relieved by specific checkpoint inhibitors await independent confirmation\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 6, 12, 13]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 13, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [5, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 12, 16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 7, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [5, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CASP3\",\n      \"BID\",\n      \"SDC1\",\n      \"GSDME\",\n      \"PRF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Granzyme B (GZMB) is a caspase-like serine protease stored with perforin and serglycin in cytotoxic granules of CTLs and NK cells that initiates target cell death through both caspase-dependent and caspase-independent proteolytic pathways. Upon immunological synapse formation, perforin creates transient plasma membrane pores enabling rapid GzmB entry into target cells — facilitated by CI-MPR/IGF2R receptor-mediated uptake — where GzmB directly cleaves Bid to activate the mitochondrial apoptotic pathway and activates caspase-3, which in turn processes caspase-6 and GSDME to trigger pyroptosis [PMID:11081635, PMID:11085743, PMID:8900201, PMID:32188940]. GzmB also directly cleaves nuclear substrates DNA-PKcs and NuMA independently of caspases and remodels extracellular matrix by cleaving vitronectin, fibronectin, and laminin [PMID:9586635, PMID:15843372]. Cytosolic SERPINB9/PI-9 protects effector lymphocytes from misdirected GzmB, transcription is controlled by synergistic AP-1/CRE promoter elements, and post-transcriptional regulation by miR-27a* and ZFP36L1 tunes GzmB protein output in activated lymphocytes [PMID:8910377, PMID:8219227, PMID:21960590].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Molecular cloning established GZMB as a novel serine protease gene specifically induced in activated human T lymphocytes, resolving the molecular identity of granule-associated cytotoxic protease activity.\",\n      \"evidence\": \"cDNA cloning, sequencing, and Northern blot in mitogen-stimulated T cell clones\",\n      \"pmids\": [\"2953813\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"enzymatic specificity and substrates unknown\", \"no functional cytotoxicity assay performed\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Gene structure analysis revealed GZMB encodes each catalytic triad residue on a separate exon with two unique intron positions, placing it in a distinct serine protease subfamily separate from classical trypsin-like enzymes.\",\n      \"evidence\": \"genomic cloning and intron–exon mapping\",\n      \"pmids\": [\"3264185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"substrate specificity not yet determined\", \"relationship between gene structure and Asp-ase activity unexplored\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Mapping the transcriptional control of GZMB showed that synergistic action of an AP-1 element and a CRE in the promoter, with critical helical spacing, drives T cell–specific expression in response to TCR and IL-2 receptor signals.\",\n      \"evidence\": \"promoter-reporter mutagenesis in T cell lines (1990–1993) and transgenic mouse reporter assays (1991)\",\n      \"pmids\": [\"2233710\", \"1761544\", \"8219227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"identity of transcription factor complexes binding the AP-1/CRE composite element not resolved\", \"chromatin-level regulation not addressed\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Two key mechanistic questions were answered simultaneously: SERPINB9/PI-9 was identified as a fast-acting cytosolic inhibitor that protects killer cells from self-inflicted GzmB damage, and GzmB was shown to initiate a caspase cascade by activating caspase-3, which then processes caspase-6 to cleave lamins.\",\n      \"evidence\": \"recombinant serpin–protease kinetics and cytotoxicity inhibition assay; in vitro cleavage cascade reconstitution with caspase mutagenesis\",\n      \"pmids\": [\"8910377\", \"8900201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"upstream initiating event in target cells (mitochondrial vs. direct caspase activation) unresolved\", \"physiological relevance of PI-9 in vivo not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Discovery that GzmB directly cleaves nuclear substrates DNA-PKcs and NuMA generating fragments distinct from caspase products established a parallel caspase-independent execution pathway.\",\n      \"evidence\": \"in vitro cleavage assays and immunoblots of CTL-treated target cells\",\n      \"pmids\": [\"9586635\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"relative contribution of caspase-dependent vs. -independent pathways to cell death in vivo unknown\", \"full substrate repertoire not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Two foundational discoveries resolved GzmB's upstream activation mechanism and entry route: direct Bid cleavage was established as the essential initiating step for mitochondrial apoptosis, and CI-MPR/IGF2R was identified as the cell-surface receptor mediating GzmB uptake.\",\n      \"evidence\": \"Bid cleavage-site and BH3 mutants with Bcl-2 epistasis; CI-MPR blocking antibodies, CI-MPR-deficient cells, and in vivo allograft rejection\",\n      \"pmids\": [\"11085743\", \"11081635\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"perforin's mechanism of cytosolic delivery versus CI-MPR endosomal uptake debated\", \"structural basis of GzmB–CI-MPR interaction unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Rab27a was identified as essential for late-stage exocytosis of GzmB-containing cytotoxic granules, linking granule trafficking machinery to killer cell function.\",\n      \"evidence\": \"Rab27a-deficient (ashen) mouse CTLs with cytotoxicity and secretion assays\",\n      \"pmids\": [\"11266473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"downstream effectors of Rab27a at the granule membrane not identified\", \"whether Rab27a acts identically in human CTLs untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Biochemical isolation of GzmB–serglycin–perforin macromolecular complexes from granules showed that GzmB is secreted exclusively in these complexes and delivered to the cytosol by perforin without producing stable plasma membrane pores.\",\n      \"evidence\": \"granule biochemistry with size-exclusion chromatography, ELISA, and membrane permeabilization assays\",\n      \"pmids\": [\"11911826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"stoichiometry of serglycin complex not determined\", \"mechanism by which perforin releases GzmB from serglycin in the cytosol unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that GzmB cleaves ECM proteins vitronectin, fibronectin, and laminin revealed a perforin-independent extracellular function in ECM remodeling, cell detachment, and anoikis.\",\n      \"evidence\": \"in vitro cleavage of purified ECM substrates, cell detachment assays, migration/invasion assays\",\n      \"pmids\": [\"15843372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"in vivo relevance of ECM cleavage in tumor surveillance or tissue injury not established\", \"full spectrum of extracellular substrates unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Real-time imaging resolved the kinetics of GzmB delivery: perforin forms transient pores lasting <80 seconds at the synapse, sufficient to deliver lethal GzmB amounts that trigger caspase activation within 2 minutes; separately, hypoxia-induced autophagy in target cells was shown to degrade internalized GzmB in autophagosomes, representing a tumor immune evasion mechanism.\",\n      \"evidence\": \"time-lapse microscopy of human CTL synapses with calcium and caspase reporters; BECN1 knockdown with NK cytotoxicity assays and in vivo tumor models\",\n      \"pmids\": [\"23377437\", \"24101526\", \"24248158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"molecular mechanism of GzmB recognition by autophagosomes unresolved\", \"whether autophagy-mediated GzmB degradation occurs broadly across tumor types untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Post-transcriptional regulation of GZMB by miR-27a* was established: miR-27a* directly binds the GzmB 3′UTR, suppresses protein expression, and reduces NK cytotoxicity in vitro and tumor control in vivo.\",\n      \"evidence\": \"3′UTR luciferase reporter, miRNA knockdown in NK cells, tumor xenograft model\",\n      \"pmids\": [\"21960590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether miR-27a* is regulated during physiological immune responses unknown\", \"combinatorial miRNA regulation of GzmB not systematically addressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"GzmB was shown to directly cleave GSDME at the caspase-3 cleavage site, converting target cell apoptosis to pyroptosis; this GzmB→GSDME axis amplifies anti-tumor immunity by enhancing macrophage phagocytosis and lymphocyte infiltration, but also drives CAR T cell-associated cytokine release syndrome via secondary GSDMD activation in macrophages.\",\n      \"evidence\": \"in vitro GzmB cleavage of recombinant GSDME, GSDME-KO mice, perforin-KO mice, CAR T cell CRS model with macrophage depletion\",\n      \"pmids\": [\"32188940\", \"31953257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"relative contribution of direct GSDME cleavage vs. caspase-3-mediated GSDME cleavage during physiological killing not quantified\", \"structural basis of GzmB–GSDME recognition unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CRISPR knockout of GZMB in primary human CD8+ T cells demonstrated that GzmB is required not only for cytotoxicity but also for CD8+ T cell-mediated immune suppression, broadening its functional role beyond target cell killing.\",\n      \"evidence\": \"CRISPR-Cas9 RNP KO in primary human CD8+ T cells with in vitro suppression assay\",\n      \"pmids\": [\"38607279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism by which GzmB mediates suppression (target cell apoptosis vs. cytokine processing) unresolved\", \"in vivo confirmation in regulatory CD8+ T cell context lacking\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"ZFP36L1 was identified as the post-transcriptional brake that keeps GzmB protein low despite abundant mRNA in tumor-infiltrating CD4+ cytotoxic T cells; checkpoint blockade relieves this brake, and Zfp36l1 deletion is sufficient to unleash GzmB protein and promote tumor control.\",\n      \"evidence\": \"Zfp36l1 constitutive expression and genetic deletion in CD4+ T cells with anti-CTLA-4 treatment and tumor growth assays (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"direct RNA-binding site of ZFP36L1 on GZMB mRNA not mapped\", \"pending peer review\", \"whether this mechanism operates in CD8+ T cells untested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"SDC1 (syndecan-1) was identified as a direct GzmB substrate whose cleavage at Val-225/Asp-228 blocks autophagosome maturation by displacing TGM2 from lysosomes, linking GzmB's proteolytic activity to suppression of cytoprotective autophagy in glioblastoma.\",\n      \"evidence\": \"in vitro cleavage site mapping, uncleavable SDC1 mutant rescue, TGM2 lysosome localization, xenograft radiosensitization model\",\n      \"pmids\": [\"41378763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether SDC1 cleavage by GzmB occurs in non-GBM contexts unknown\", \"structural mechanism of TGM2 displacement not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the complete in vivo substrate repertoire of GzmB, the structural basis of substrate selectivity, the precise mechanism by which perforin releases GzmB from serglycin complexes into the target cytosol, and the relative contributions of the Bid/mitochondrial, direct caspase, and GSDME pyroptotic pathways across different physiological and pathological contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"comprehensive in vivo substrate identification lacking\", \"no crystal structure of GzmB–substrate complex available\", \"perforin–serglycin dissociation mechanism unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [6, 7, 8, 14, 22, 29]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 6, 7, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [10, 11, 19, 31]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [11, 14]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 10, 13, 15, 19, 28]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 7, 8, 22, 23]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [17, 18, 29]}\n    ],\n    \"complexes\": [\n      \"GzmB–serglycin–perforin granule complex\"\n    ],\n    \"partners\": [\n      \"PRF1\",\n      \"SERPINB9\",\n      \"BID\",\n      \"CASP3\",\n      \"GSDME\",\n      \"IGF2R\",\n      \"RAB27A\",\n      \"SDC1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}